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ABSTRACT
SEROTONERGIC INVOLVEMENT IN THE BEHAVIORAL DEPRESSION 
PRODUCED BY INTERMITTENT SWIM STRESS
John Paul Christianson 
University o f New Hampshire May 2006
Exposure to uncontrollable stress produces a behavioral syndrome that is often 
described as “behavioral depression” in the rat. Current paradigms for inducing 
behavioral depression utilize continuous swimming or intermittent electric shock stress. 
Brown et al., developed a novel strategy that combined these stressors to produce the 
intermittent swim stress (ISS) protocol. The purpose of this thesis was to define the 
behavioral outcomes o f ISS that resemble behavioral depression and to begin 
neurochemical characterization o f the phenomenon.
Two hallmark features o f behavioral depression are immobility, as determined in 
a Forced Swim Test (FST) and escape learning deficits, as determined by operant tasks 
such as the shuttlebox test. In Experiment 1, rats were exposed to either ISS or 
confinement and, 24 hours later, subjected to a swim escape test (SET) designed to 
analogue the shuttlebox test in a swim context. Prior stress interfered with escape 
acquisition in the SET.
The results o f previous studies suggest that stress causes a temporary activation of 
the brain serotonin (5-HT) system that is necessary and sufficient for producing
viii
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behavioral depression. If  this hypothesis is true in the ISS paradigm, then enhancing or 
inhibiting 5-HT transmission during stress should exacerbate or block the development of 
behavioral depression, respectively. In Experiment 2 the selective 5-HT uptake inhibitor, 
fluoxetine, was administered prior to ISS or confinement; 24 h later the FST was used to 
detect behavioral immobility. ISS, but not fluoxetine, significantly increased immobility 
in the FST. In Experiment 3, the 5-HT uptake enhancer, tianeptine, was administered in 
place o f fluoxetine. Again ISS increased immobility in the FST, but tianeptine had no 
effect. These results suggested that 5-HT is not a critical mediator o f ISS induced 
behavioral depression. However, some authors have raised concern that tianeptine does 
not act directly on 5-HT and, therefore, the results o f Experiment 3 are difficult to 
interpret. Experiment 4 utilized the 5-HT synthesis inhibitor, para-chlorophenylaline 
(PCPA) to deplete 5-HT before stress. PCPA did not alter immobility in the FST. Taken 
together, these experiments indicate that ISS produces a significant behavioral depression 
manifested as increased immobility and poor escape learning. Furthermore, the current 
data do not support the hypothesis that the 5-HT system is a critical substrate of 
intermittent swim stress. Results are discussed within a framework o f the neurobiology of 
uncontrollable stressors.
ix
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CHAPTER I
INTRODUCTION
Stress is implicated in the pathology of many psychological conditions. 
Importantly, stress is typically identified as a risk factor for depression and anxiety 
(Hammen, 2005). Current therapies for depression however, are not satisfactory. Many 
patients continue to suffer despite many treatment attempts; while some find relief, they 
must endure several uncomfortable side-effects o f antidepressant drugs (Nestler, Barrot, 
DiLeone, Eisch, Gold, & Monteggia, 2002). It is, therefore, interesting to learn about the 
biological elements that respond to stress and that regulate stress-induced behaviors that 
can harm people. To do this, an organism must be exposed to a stressor and then be 
carefully observed. One such procedure was developed in our laboratory and employs 
intermittent swim stress (ISS; Brown, Hurley, Repucci & Drugan, 2001). This thesis 
describes the development o f this paradigm and studies that begin to establish the 
neurochemical basis o f the behavioral consequences of ISS.
Depression
Symptoms. Several theoretical concepts and neurobiological systems comprise 
the background for depression research. The following section intends to review these 
topics: the nature o f depression and its treatment, the use of rodent models, and the 
behavioral endpoints used in depression research. Major Depression is a psychiatric 
disorder that is characterized by the following behavioral symptoms: depressed mood;
1
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irritability; low self esteem; feelings of hopelessness, worthlessness and guilt; decreased 
ability to concentrate and think; change in appetite or weight; sleep disturbance; fatigue; 
agitation; decreased interest in rewarding activities (anhedonia); and recurrent thoughts of 
death or suicide (DSM-IV, 2000). While these symptoms often appear with other 
psychiatric disorders, including Post Traumatic Stress Disorder (PTSD), Bipolar 
Disorder, and Anxiety disorders, Major Depression is only diagnosed when several 
symptoms persist for over two weeks, disrupt normal social or work functioning, and 
cannot be attributed to another disorder or organic cause, such as substance abuse (DSM- 
IV, 2000). It is important to note that the symptoms of depression often manifest in 
response to traumatic injury, life stress, and grieving, but under most circumstances these 
symptoms are only temporary. Depression is a common condition with lifetime risk 
estimated to be between 3.7 and 6.7 percent with women and persons with family history 
at greater risk (Winokur, 1994). The genetic risk for depression is estimated to be 40 to 
50 percent indicating that depression is a heritable condition, however there is little 
evidence for genetic mutations in depressed persons (Fava & Kendler, 2000). Several 
environmental factors contribute to depression including trauma, life stress, aging, and 
disease (Anisman & Zacharo, 1982; Fava & Kendler, 2000; Nestler et al., 2002). Stress is 
not a causal factor for depression, but it may be an independent risk factor. Severe stress 
or trauma that causes symptoms o f depression or anxiety is classified as PTSD. Stress 
research with rodents may model PTSD as much as it does depression.
Treatment. Major depression can be treated with several therapies. Psychological 
therapies such as psychotherapy, cognitive, behavioral, and interpersonal therapies can 
reduce depressed symptoms; a combination o f cognitive and behavioral therapies appears
2
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to be most effective (Winokur, 1994). Ideal treatment combines psychological therapy 
with pharmacological therapy. Several effective antidepressant drugs have been 
developed that fall into six categories: tricyclic, monoamine oxidase inhibitors (MAOIs), 
atypical, serotonin-specific reuptake inhibitors (SSRIs), dual-action, and norepinephrine- 
specific reuptake inhibitors (NSRIs). The acute effects of these drugs is to increase the 
synaptic levels of monoamines, specifically serotonin (5-Hydroxytryptamine, 5-HT) and 
norepinephrine (NE) by either blocking reuptake transporters, autoreceptors, and/or 
deactivating enzymes (Julien, 2001). The long-term therapeutic effects o f antidepressants 
are desensitization to 5-HT and NE, and upregulation of cAMP response element binding 
protein (CREB) and its genetic target brain-derived neurotrophic factor (BDNF, Duman, 
Heninger & Nestler, 1997). The fact that antidepressants modulate neuroplasticity and 
neurogenesis has shifted attention from the monoamines towards the biological 
components related to those processes such as cytokines and nerve growth factors. 
Despite many technological advances in the treatment of depression, current treatments 
must be improved to reduce side-effects, decrease pharmacological lag, and treat 
“treatment-refractory” depression.
Using Animals to Model Depression. Animal models are necessary to study the 
neurobiological mechanisms that contribute to depression. Experiments require control 
over every environmental variable that could affect the subject. These variables include 
genetic background, diet, handling and treatment history; ultimately, control o f these 
variables is sacrificed in human research. In addition, invasive, stressful, 
pharmacological, and genetic treatments that would be unethical in humans can be 
administered to animals. Laboratory conditions provide the precision to draw cause-and-
3
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effect conclusions about pharmacological, behavioral, and surgical manipulations that 
either reduce or induce depressed symptoms. It is impossible to study the effects of stress 
on behavior and physiology with in vitro models; therefore it is necessary to use living 
subjects in stress research. The rat is used in a great deal o f psychological research 
because of its anatomical and endocrine similarities with humans. Rats also exhibit 
several behaviors that are objectively observed in the lab. How can depression be induced 
and objectively quantified in a rat?
That exact question has been debated for decades. Several authors have discussed 
advantages and disadvantages o f animal models (Cryan, Markou & Lucki, 2002; Henn & 
Bunney, 1987; Henn, Edwards, Muneyyici, 1993; Porsolt, 2000), but they ultimately 
revert to a set o f guidelines established by McKinney & Bunney in 1969. Their 
suggestions require that: the model be analogous to the human condition in manifestation 
and/or symptoms; the model uses a behavioral endpoint/s that can be measured 
objectively; the “depressed” behavior should be reversed by treatment-specific modalities 
that are effective in humans, i.e. antidepressants, but not stimulants; and the procedure 
should be reproducible and reliable between laboratories. Of the diagnostic criteria for a 
Major Depressive Episode (DSM-IV, 2000), several symptoms are impossible to model 
in rodents including: depressed mood, low self-esteem, hopelessness, guilt, and thoughts 
of death and suicide. However, some symptoms can be operationally defined in rodents 
including cognitive deficits, changes in appetite, change in weight, sleep abnormalities, 
reduced motivation, fatigue, and anhedonia. Several animal models use stress to produce 
these symptoms and meet McKinney & Bunney’s criteria as valid tools.
4
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It is too easy to identify a behavior in the rat and provide an anthropomorphic 
explanation for its utility. For example, freezing is a stereotypical defensive behavior that 
occurs when a rat is placed in a threatening environment (Bolles & Fanselow, 1980). 
Freezing is commonly used as an index of “fear” or “anxiety” because anxiolytic drugs 
like diazepam eliminate freezing and anxiogenic drugs like beta-carbolines evoke 
freezing. Unfortunately, many animal models of depression are described in similar 
anthropomorphic terms. As new animal models are presented, special attention should be 
given to their validity, not only in that they produce behaviors that resemble depression, 
but that the behavioral methods are driven by neurobiological hypotheses relevant to the 
clinical picture o f depression (Holmes, 2003). A “neurobehaviorally mechanistic 
approach” (Holmes, 2003 p. 144) requires that specific neurobiological mechanisms are 
hypothesized to regulate symptoms of depression and that those mechanisms can be 
manipulated in laboratory animals and are supported by clinical observations (Holmes, 
2003). The experiments included in this thesis tested a hypothesized neurobiological 
basis for stress-induced depression that implicated the brain serotonin system.
Developing the Intermittent Swim Stress Model 
The intermittent swim stress model was developed as a hybrid between two well- 
established, but procedurally different, paradigms: learned helplessness (Maier & 
Seligman, 1976) and behavioral despair (Porsolt, LePinchon & Jalfre, 1977). These 
paradigms are similar in that exposure to acute stress results in a syndrome o f behavioral 
depression, but they are distinct for two reasons: a) learned helplessness uses an 
intermittent stressor while behavioral despair uses a continuous stressor while; b) learned 
helplessness is observed in tests o f conditioned fear and aversive, instrumental learning
5
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while behavioral despair is observed in a test o f activity. It is necessary to review the 
hallmark characteristics of the learned helplessness and behavioral despair models before 
describing the development of the ISS paradigm.
Learned Helplessness
In 1967, Overmier & Seligman, and Seligman & Maier published the first reports 
of a behavioral phenomenon that has since been described as learned helplessness. The 
observation was that exposure to uncontrollable electric shocks in dogs interfered with 
the subsequent acquisition of an avoidance/escape response in a shuttle-box. While dogs 
without prior stress readily learned the contingency for avoidance, stressed dogs appeared 
to be helpless and failed to escape. Shortly after this discovery, Maier, Albin & Testa 
(1973) and Weiss & Glazer (1975) observed the same phenomenon in rats, a more 
appropriate subject for animal research. Furthermore, learned helplessness has been 
observed in many species from humans to cockroaches (Maier & Seligman, 1976)!
An elegant aspect o f most research on learned helplessness is the use o f the triadic 
stress paradigm. In the triadic design, rats are assigned to escapable stress, yoked- 
inescapable stress, or restraint. The escape and yoked subjects receive equal exposure to 
stress but the escapable-stress subject is able to perform an instrumental response that 
terminates stress. Typically the manipulandum is a wheel or lever. The triadic design 
allows for the study o f controllability as well as stress per se. As the learned helplessness 
theory maintains, yoked subjects learn that the onset and offset o f stress are not 
contingent on any behavioral response while the escapable-stressed subjects learn a 
contingency between an operant response and the termination o f stress. A subsequent 
task, where escape is possible, is interfered with by prior inescapable stress. These so-
6
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called helpless subjects fail to acquire the escape or avoidance contingencies in the later 
task (for a more elaborate review see Maier & Seligman, 1976). In addition, exposure to 
intermittent shock produces a syndrome o f behavioral and physiological consequences 
including, but not limited to, enhanced fear conditioning (Maier, 1990; Minor, 1990), 
avoidance-escape interference (Maier, Albin & Testa, 1973; Weiss & Glazer, 1975), 
anorexia (Dess, Choe & Minor, 1998), reduced home-cage running activity deficits 
(Desan, Silbert & Maier 1988), analgesia (Drugan, Ader & Maier, 1985; Jackson, Maier 
& Coon, 1979) and hypothalamic-pituitary-adrenal (HPA) axis stimulation (Maier, Ryan, 
Barksdale & Kalin, 1986). Animals that display these behaviors are considered to be in a 
state o f “behavioral depression” (Weiss et al., 1981).
Learned helplessness has been critically evaluated and acknowledged as a useful 
model for studying depression (Henn, Edwards & Muneyyirci, 1993; Wilner, 1984). The 
strength of the learned helplessness model is that it seems to analogue a clinical course of 
depression, in that stress or anxiety precedes the onset o f depressed symptoms (Petty,
1996). Furthermore, therapies that are effective in humans including exercise 
(Greenwood et al., 2003) electroconvulsive therapy, and tricyclic, MAOI and SSRI 
antidepressants are capable of preventing or reversing the learned helplessness effect 
(Sherman & Petty. 1980; Sherman, Sacquitne & Petty, 1982).
Behavioral Despair
Porsolt, Le Pinchon, & Jalfre presented the behavioral despair model as a 
preclinical screen for antidepressant drugs in rodents (1977). In spite o f its name, 
behavioral despair is not necessarily a model of psychological stress because it does not 
involve any explicit learned behaviors or cognitive processes. During continuous swim,
7
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rather, an observer quantifies the subject’s inactive behaviors in the form of an immobile 
posture (i.e., floating) described as “behavioral despair” (Porsolt, et al., 1977). Behavioral 
despair is induced in rats by exposure to a 15-min continuous swim in ambient water and 
24 h later, rats are placed into the same swim tank and observed for immobility in a 5- 
min Forced Swim Test (FST). A wide range o f therapeutic treatments reverse behavioral 
despair including electroconvulsive therapy, and tricyclic, atypical, and MAOI 
antidepressants (Borsini & Meli, 1988). However, serotonergic compounds including the 
selective serotonin reuptake inhibitors (SSRIs) do not consistently reverse behavioral 
depression using the traditional observation method described by Porsolt. The procedure 
for observing the FST was revised by Detke, Rickels & Lucki (1995) to be more sensitive 
to serotonergic drugs. The modified FST has gained wide acceptance and many 
laboratories have reported reversal o f behavioral despair with SSRIs and novel 
antidepressant compounds including insulin-derived nerve growth factor (Hoshaw, 
Mahlberg & Lucki, 2005) and brain derived nerve growth factor (Shiryama, Chen, 
Nakagawa, Russel & Duman, 2002; for a review see Cryan, Valentino & Lucki, 2005). 
Intermittent Swim Stress
Brown, Hurley, Repucci, and Drugan (2001) developed an ISS procedure that is a 
hybrid of the learned helplessness and behavioral despair procedures. Electric tail-shock 
was replaced with intermittent, inescapable swim in ambient temperature, 23 °C, water. 
Like the learned helplessness paradigm, the ISS procedure involved 80, 5-sec swim trials 
administered on an average o f one trial every 60 sec in an apparatus that has the same 
dimensions to that used for the FST. Preliminary study of this model revealed that rats 
exposed to ISS in ambient water did not differ from confined controls on several
8
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measures including fecal boli, conditioned fear, open field exploration, running-wheel 
activity (Brown, master’s thesis 1999), shuttlebox learning, or analgesia but, escape-yoke 
differences were found in alcohol reactivity and shuttlebox escape (Brown, et al., 2001). 
The failure to find a stress effect in these preliminary studies was attributed to the 
possibility that the ambient water temperature swim was not a strong enough stressor to 
produce lasting and robust behavioral responses. After some pilot investigations, 80 trials 
in 15°C water appeared to be severe, but not life-threatening. Therefore, the following 
experiments used 15°C water to increase the potency of the stressor.
In our first study using cold water we found that 80, 5-sec trials o f ISS in cold 
water increased immobility in the FST given 24 h after stress treatment (Christianson & 
Drugan, 2005) but did not affect conditioned fear or shuttlebox escape (Christianson, 
master’s thesis 2002). The learned helplessness effect seems to be enhanced when there is 
contextual consistency between stress and test situations (Minenka, Cook & Miller, 1984; 
Minor & Lolordo, 1984). Therefore, I hypothesized that the failure to detect swim stress 
effects in the shuttlebox could be because the aversive stimuli in the stress and test 
situations were different (e.g., swim induction, shock test). To increase similarity of 
stimuli in stress and test situations, I designed a swim escape test (SET) that is 
procedurally similar to the classic shuttlebox escape test. The SET is conducted in the 
same apparatus as the intermittent swim stress treatment but there is an omnidirectional 
lever suspended at the surface o f the water that a rat can press to raise the apparatus from 
the water and turn off a tone that signals escape. The escape requirements are the same as 
those used in a traditional shuttlebox test. If  ISS interferes with the cognitive processes 
required for escape learning, then the swim escape test (SET) should be maximally
9
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sensitive to that effect due to the degree o f stress-to-test context homology. In 
Experiment 1A rats treated with 80 trials of ISS showed significantly slower escape 
latencies in the swim escape test (Christianson & Drugan, 2005 and Experiment 1A, 
Chapter 2). While the observed escape deficit was statistically significant, the magnitude 
was small. Therefore Experiment IB aimed to replicate and strengthen the SET deficit 
produced by increasing the number o f swim stress trials from 80 to 100.
10





All experiments used male Sprague-Dawley rats (Charles River Labs, MA) 
weighing 230-300 grams on the first day of treatment. Upon arrival rats were group 
housed in polyethylene tub cages (4 rats per cage); on the first day o f treatment rats were 
transferred to single cages. Rats had free access to standard rat chow (Purina) and tap 
water at all times in the vivarium. The vivarium maintained a 12 hour light/dark cycle 
with lights on at 6:00AM. Rats were handled in accordance with Public Health Services 
“Guidelines for humane treatment of laboratory animals.” In addition, the procedures 
were reviewed and approved by the University o f New Hampshire Institutional Animal 
Care and Use Committee (IACUC; APPENDIX A).
Apparatus
Swim Stress. ISS was administered in Plexiglas cylinders (21 X 42 cm - dia. X H) 
with a 14-inch galvanized wire mesh floor suspended over a tank o f 15°C water. On a 
swim trial, the cylinders lowered into water to a depth of 20 cm. Space heaters blew 
warm air (= 36°C) into the cylinders to minimize body temperature loss during inter-trial- 
intervals. The swim stress apparatus was controlled by a computer with Med-PC 
hardware and software (Med-Associates, Georgia, VT). At a separate time, confined rats
11
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were placed in the same Plexiglas cylinders but were suspended over an empty tank. The 
confined rats were subjected to the same handling, noise and movement as the stressed 
rats but never entered the water.
Swim Escape Test. The SET was administered in the same apparatus used for ISS 
with three modifications. First, an omnidirectional lever (Med-Associates, Georgia, VT) 
hung in the swim chamber just breaking the water surface at a distance 7 cm from the 
chamber wall. Second, a Sonalert tone generator (Mallory, Model: SC2628) was located 
above the chamber. Third, water temperature was raised to 23°C.
Procedure
After a 7-10 day acclimation period rats were randomly assigned to ISS or 
confined treatments, n = 12 / group. The ISS group received 80, 5-sec swims in cold 
water (15°C) distributed on an average o f 1 trial every 60 sec (VI-60). At the same time, 
confined rats were placed in shorter chambers that were exposed to the same movement, 
noise, and handling as the stressed rats, but not to swimming. Following the stress 
session, rats were towel-dried and placed under incandescent lamps for 30 minutes before 
returning to the vivarium. 24 h later all rats received the SET. The SET was designed to 
model the temporal parameters of the shuttlebox escape test used to detect learned 
helplessness (Maier, Albin & Testa, 1973). Therefore, the SET consisted of 5 FR-1 
escape trials requiring 1 lever press to terminate swim and 25 FR-2 escape trials requiring 
2 presses to terminate swim. Trials were randomly presented on a VI-60 sec schedule. A 
5 sec tone (75db) signaled the beginning o f each trial, and then the swim chamber 
lowered into the water. An appropriate escape response raised the rat from the water and
12
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turned off the tone. If 30 sec elapsed without a response, then the trial was terminated by 
the computer. The controlling computer recorded escape latencies for each trial.
Results and Discussion 
Mean escape latencies for ISS and confined groups are shown in Figure 1. No 
significant differences were found between groups on FR-1 trials, t(22) = -0.26, p  = 0.80. 
A repeated measures 2 X 5  ANOVA with stress as a between-subjects factor and FR-2 
blocks as a within-subjects factor revealed a significant main effect o f blocks, F(4, 88) = 
9.08, p  < 0.001, and a significant treatment X block interaction F(4, 88) = 2.88,p  = 0.03. 
The main effect of stress pretreatment only approached significance, F(4, 88) = 3.70, p  = 
0.07. A post hoc test for a stress X block X contrast interaction was significant for a 
quadratic trend, F (1, 22) = 6.05, p  = 0.03. This contrast detected significantly different 





FR-1 2 3 4 51
FR-2
Blocks of 5 Trials
Figure 1. M ean  (+/-) SEM e s c a p e  la ten c ie s  in th e  swim e s c a p e  test in 5 trial blocks. 
*Stress X Block X Q u ad ra tic  trend , p  < 0.05, n = 12/group. •  ISS, o C onfined
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Visual inspection o f the escape latencies for individual subjects revealed that 5 of 
12 stressed rats performed at or below the mean time of confined rats. A mean latency to 
escape for the entire SET was computed for each subject. The distribution of individual 
subject means is depicted in Figure 2. It appeared that after 80 trials o f ISS, some stressed 
rats were “vulnerable” and others were “resilient” to stress effects in the SET. This 
pattern is not unique to the ISS paradigm. Maier & Seligman (1976) noted that in most 
experiments on the learned helplessness phenomenon, some “exceptional” subjects 
learned to escape despite prior exposure to inescapable stress. Other authors have 
identified individual differences in shuttlebox performance as resilient and vulnerable 














Figure 2. Individual su b jec t m e a n  e s c a p e  la ten c y  c o m p u te d  ac ro ss  all 30 trials of the  
SET test. G roup m e a n  is d e p ic te d  by a  solid horizontal line.
The results o f Experiment 1A provide the first evidence that ISS could produce 
behavioral consequences that are similar to that produced by intermittent shock in the
14
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learned helplessness paradigm. 80 trials of ISS produced a modest escape deficit in the 
SET. In addition, stressed rats appeared to have different behavioral reactions in the SET 
in that some rats performed poorly while others learned to escape compared to confined 
controls. This behavior pattern could be the result of innate individual differences for the 
SET test or to innate dispositions to stress. If  the later is true, then a more severe stress 
experience should cause more rats to appear vulnerable and therefore strengthen the 
effect o f ISS in the SET. Experiment IB intended to test this hypothesis by increasing the 
number of stress trials from 80 to 100. In a pilot study, a portion o f stressed rats emitted 
ultrasonic vocalizations during intermittent swim stress (Soucy, Christianson & Drugan, 
unpublished observations). Ultrasonic vocalizations could be perceived as stressful and 
affect the “control” experience of confined rats. Therefore, confined animals were run 
separately and a naive control group was added to the design.
Experiment IB Method
Subjects
24 rats o f the same strain and source were used in this experiment. Housing 
conditions were the same for those used in Experiment 1A (APPENDIX B)
Apparatus
The same swim stress and SET apparatus used in Experiment 1 were used. 
Procedure
After a 7-10 day acclimation period rats were randomly assigned to ISS (n = 12), 
confined (n = 6), or naive (n = 6) treatments. The ISS group received 100, 5-sec swims 
in cold water (15°C) distributed on a VI-60sec schedule. At a separate time, confined rats
15
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were placed in the swim chambers and exposed to the same movement, noise, and 
handling as the stressed rats, but not to swim. Following the stress session, rats were 
dried and placed under incandescent lamps for 30 minutes before returning to the 
vivarium. Naive rats were weighed and placed in single cages. 24 h later all rats received 
the SET as described in Experiment 1.
Results
Mean escape latencies for ISS and pooled control groups are shown in Figure 3. 
An a priori hypothesis that confined and homecage controls would not differ was 
confirmed. No difference was found between the performance o f confined or homecage 
controls on the FR-1 block, t(20) = 1.01, p  = 0.33, or on the FR-2 blocks, repeated 
measures 2 X 5  ANOVA with controls as between subjects factor and blocks as a within 
subjects factor F( 1, 10) = 0.86, p  = 0.38. Therefore, data from confined and home cage 
controls were combined to form a single control group, n = 12. No effect of stress was 
detected on the FR-1 block, t{21) = 1.89,/? = 0.07. A repeated measures 2 X 5  ANOVA 
with stress (vs. controls) as a between-subjects factor and FR-2 blocks as a within- 
subjects factor indicated a main effect in that ISS significantly increased escape latency 
on the FR-2 trials, F( 1, 21) = 5.68,/? = 0.03, and a significant main effect for FR-2 
blocks, F(4, 84) = 7.71,/? < 0.001, but no significant stress X block interaction.
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Blocks of 5 Trials
Figure 3. M ean  (+/-) SEM e s c a p e  la ten c ies in th e  swim e s c a p e  test in 5 trial-blocks afte r 
100 trials of ISS. Control represents d a t a  p o o led  from co n fin ed  a n d  h o m e  c a g e  tre a te d  
subjects. A significant main e ffec t for stress is p resen t on th e  FR-2 trials, p  < 0.05.
•  ISS, o C onfined
Discussion
Experiments 1A and IB demonstrated that exposure to intermittent swim stress 
interferes with instrumental escape learning in the SET. Similar to the work by Maier et 
al., (1973), stressed and confined rats performed comparably on FR-1 trials, but when the 
escape demand increased to FR-2, rats exposed to ISS performed poorly compared to 
controls. Escape interference in the SET is consistent with data from other stress models. 
First, stress-induced learning deficits have been reported by others on instrumental swim- 
escape tasks (Alentnor, Kay & Richter, 1977; Irwin, Suissa & Anisman, 1980). Second, 
parametric increases in stress induction are found to increase the behavioral (Maier et al 
1973) and neurochemical consequences of stress (i.e. Takase et al., 2005). Early research 
in the learned helplessness literature employed 80 trials o f intermittent shock, but, 
recently, it is more common to use 100 trials. ISS shows a similar pattern that the more 
severe 100-trial ISS treatment magnified the learning deficit found after 80-trials.
17
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Furthermore, the exceptional performance o f some rats exposed to ISS appears to be 
similar to observations in the learned helplessness paradigm (Maier & Seligman, 1976).
While the behavioral consequences of ISS are consistent with those of behavioral 
despair (i.e. increased immobility in the FST; Christianson & Drugan, 2005) and learned 
helplessness (i.e. SET performance deficit), it is possible that the physiological and 
psychological substrates o f the ISS phenomena are unique to the stress-induction and test 
procedures. Several hypotheses have been presented to explain stress-induced immobility 
and stress-induce escape interference. In the original report, Porsolt and colleagues 
(1977) describe the immobile posture as a behavioral expression of “hopelessness.” Such 
an anthropomorphic description overlooked a parsimonious hypothesis that during a 15 
min exposure to inescapable swimming, animals quickly learn that no escape is possible 
and therefore adopt a passive behavior as a way to preserve energy in the event that the 
context would change and escape was possible. The 5 min FST, therefore, merely detects 
such an adaptation rather than a “hopeless” or depressed rat. Indeed, several authors have 
argued that the behavioral depression observed in the FST is better described as learned 
immobility (DePablo, Parra, Segovia & Guillamon, 1989; Hawkins, Hicks, Phillips & 
Moore, 1978). Because the behavioral despair model involves only a simple stress 
induction with no manipulation for psychological parameters such as controllability or 
predictability it is very difficult to argue for a learned response or one internal 
motivational state, such as hopelessness, over another. Therefore, it has become common 
to discuss behavioral despair in objective terms that describe swim induced behaviors 
(such as climbing, diving, swimming and immobility) or physiological consequences, 
such as elevation of gluccocorticoid hormones in plasma (Connor, Kelly & Leonard,
18
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1997). From a psychological perspective it appears that the 5 min FST is detecting a 
behavioral adaptation that is one of energy conservation (i.e. immobility) in the presence 
of an unsolvable problem (i.e. the inescapable swim). Pretreatment with either continuous 
swim (Borsini & Meli, 1988) or intermittent swim (O, Neill & Valentino, 1982; Brown et 
al., 2001; Christianson & Drugan, 2005) speeds the onset o f immobility. However, 
intermittent-escapable swim stress does not influence immobility (Drugan et al., 2005). In 
the context o f an animal model o f depression, it is critical to note that immobility is 
reduced by antidepressant drugs regardless o f a stress pretreatment (Overstreet, Keeney,
& Hogg, 2004).
Behavioral immobility could also be a learned response to experience with 
inescapable stress (Anisman, deCatanzaro & Remmington, 1978; Bracewell & Black, 
1974; Glazer & Weiss, 1976). Alternatively the learned helplessness hypothesis can 
account for immobility in that dissociation between actions and outcomes would reduce 
the motivation for an organism to attempt escape behaviors in any context (Jackson, 
Alexander, & Maier, 1980) and, specifically, to reduce the occurrence o f climbing and 
diving in the FST. Unfortunately, the current data do not favor either a learned inactivity 
or a learned helplessness hypothesis because escape behavior in the SET is confounded 
with both performance (inactivity) and acquisition of an action-outcome contingency 
(helplessness). Recently we determined that ISS interfered with escape performance in 
the Morris Water Maze (Christianson, VanHoogenstyn & Drugan, 2006 unpublished 
observations). While the water maze test requires the organism to learn more complex 
contextual contingencies (i.e. the spatial location o f a hidden platform) poor performance 
might still be accounted for by stress-induced inactivity. Although we have reason to
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believe that activity level in the water maze did not influence learning because stressed 
and control subjects swam at similar speeds.
Thus, three likely, although non-orthogonal, hypothetical explanations exist for 
ISS induced immobility, SET and water maze performance deficits. First, exposure to 
inescapable swimming increases the rat’s tendency to use a passive, energy-preserving 
behavioral strategy in the face o f subsequent stressors. Second, exposure to unpredictable 
and inescapable stress causes the rat to learn that escape occurs when the animal is 
inactive and therefore behavioral inactivity is observed in subsequent tests. Finally, 
exposure to unpredictable and inescapable stress causes a dissociation o f the animal’s 
expectation that environmental outcomes are contingent upon its actions.
It is o f great empirical interest to conduct experiments that eliminate the 
confounding variable of performance which would allow for a distinction between these 
hypotheses; however the goal o f the remaining work in this thesis was to determine the 
biological basis o f the ISS phenomena. Because behavioral immobility may be a core­
component o f ISS, the following experiments used the FST as the primary dependent 
measure. The FST offers four critical advantages over the SET. First, immobility is 
sensitive to dose-response relationships (e.g. Detke, et al., 1995). Second, the FST is a 5 
min test in which every subject, despite the presence o f active or passive behaviors, is 
exposed to the identical physical stress experience; this allows for behavioral differences 
in subsequent tests, such as the open field test for motor activity, to be attributed to prior 
stress or drug treatment. Third, the modified observation procedure developed by Detke 
et al., (1995) allows for quantification of immobility, swimming and climbing behaviors 
throughout the 5 min FST. While these behaviors are mutually exclusive, the method
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allows for characterization of the behavioral topography in the test. Behavioral 
topography is relevant because immobility, swimming and climbing behaviors may have 
unique pharmacological substrates (Cyan et al., 2002). Finally, the FST provides a 
procedural link between these experiments and a wide empirical literature because the 
FST has been used as a behavioral endpoint in both shock and swim stress research that 
utilized a variety o f physiological manipulations. The physiological components of 
uncontrollable stress are reviewed in the next chapter.
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CHAPTER III
NEUROBIOLOGICAL RESPONSES TO UNCONTROLLABLE STRESS
Over thirty years o f research has accumulated a vast literature on the biological 
consequences o f inescapable stress that may account for the neurobiological basis o f 
learned helplessness. The purpose o f this review is to compile this literature into a 
neurobiological model that mediates the variety o f behavioral responses to uncontrollable 
stress. Most recently, several experiments have determined that a major feature of learned 
helplessness is activation of the midbrain raphe serotonin (5-HT) system (e.g., Maier & 
Watkins, 1998). While 5-HT is clearly an important modulator o f brain circuits, learned 
helplessness is a multi-chemical phenomenon involving corticosterone (CORT), 
endogenous opioids, corticotrophin releasing factor (CRF), and the catecholamines. In 
this review I give an overview o f each of these neurochemical systems and their role in 
uncontrollable stress. Furthermore, I propose a neurobiological model that integrates 
important findings from many avenues o f research that represents the current 
understanding o f the neurobiological response to uncontrollable stress.
Corticosterone. Endogenous Opioids, and 
Corticotrophin Releasing Factor 
Uncontrollable stressors, including continuous swim stress (Connor et al., 1997), 
intermittent swim stress (Drugan et al., 2005) and electric shock (Maier et al., 1986) 
activate the hypothalamic-anterior pituitary-adrenal (HPA) axis and produce significant
22
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elevation o f blood adrenocorticotrophic hormone (ACTH) and CORT. CORT is released 
after a cascade o f biological events that begins in the hypothalamus. CRF is released 
from the paraventricular nucleus of the hypothalamus (PVN) which stimulates synthesis 
and release o f ACTH in the anterior pituitary gland. CRF, released from the median 
eminence into the hypophyseal-portal, travels to the anterior pituitary where it causes 
cleavage to the precursor peptide proopiomelanocortin (POMC) which produces ACTH 
and other neuroactive peptides including /1-endorphin (Akil, Watson, Young, Lewis, 
Khachaturian, & Walker, 1984). /1-endorphin is also produced in the arcuate nucleus of 
the medial basal hypothalamus which projects to the limbic system (Akil et a., 1984). 
ACTH travels through the periphery to the adrenal cortex where it stimulates synthesis 
and release o f CORT (Dunn, 1995). CORT, (S-endorphin, and CRF are major contributors 
to the stress response, each are discussed individually.
Corticosterone
CORT has high affinity for glucocorticoid receptors in the brain which provide a 
powerful negative feedback to the HPA axis. Corticosterone is able to inhibit the PVN 
and anterior pituitary directly but seems to have the strongest effect on the hippocampus 
(Sapolsky, Krey & McEwen, 1984). Indeed, the hippocampus is vulnerable to the effects 
of stress because it is rich with gluccocorticoid receptors (McEwen, Weiss, & Schwartz, 
1969). Stress and glucocorticoid exposure cause neuronal death in the hippocampus 
(Sapolsky, 2000) and inhibit production of granule cells in the dentate gyrus. However, 
antidepressants are able to reverse that effect (Fuchs & Gould, 2000; Malberg & Duman, 
2003). This damage may reduce inhibitory control o f the HPA axis from the 
hippocampus and may contribute to basal increase in HPA activity (Fleshner, Deak,
- 23
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Spencer, Laudenslager, Watkins & Maier 1995) and potentiated HPA response to 
subsequent stressors found in inescapably stressed rats (Johnson, O ’Connor, Deak, 
Spencer, Watkins, & Maier, 2002; O’Connor et al., 2003). Several research approaches 
have identified mechanisms that contribute to stress and glucocorticoid damage to the 
hippocampus.
A major functional component in the hippocampus that is affected by stress is 
synaptic plasticity. Long-term potentiation (LTP) is an increase of synapse strength 
between a terminal button and dendrite after repeated stimulation. LTP is hypothesized to 
be the biological substrate o f learning and occurs readily in neurons o f the hippocampus 
(Bliss & Collingridge, 1993). LTP involves sprouting of new dendrites between neurons 
that are firing together. This mechanism can be induced in vitro or in vivo by passing a 
high-frequency electric tetanus to an afferent axon and subsequently measuring the 
extracellular excitatory post synaptic potential (EPSP) produced by a single pulse in the 
receiving neuron. After induction of LTP, a single electrical pulse will cause a greater 
EPSP. Acute (Kim, Foy, & Thompson, 1996; Kim, Lee, Han & Packard, 2001; Foy, 
Stanton, Levine & Thompson, 1987) and chronic (Shors, Seib, Levine & Thompson,
1989) shock stress reduces LTP in rat hippocampal slices. Chronic high levels of 
corticosterone decreased LTP in vivo but low doses did not (Diamond, Bennett, Fleshner 
& Rose, 1992). However, adrenalectomy reduced, but did not eliminate, the effect of 
chronic stress on LTP (Foy, Foy, Levine & Thompson, 1990). What is intriguing is that 
escapable stress did not affect LTP (Shors et al., 1989). Together, these studies suggest 
that the influence o f glucocorticoids in LTP is biphasic, i.e. low doses enhance while high 
doses inhibit.
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An experiment by MacLennan, Drugan, Hyson, Maier, Madden & Barchas (1982) 
determined the role o f the HPA axis in the learned helplessness design. In their study, rats 
were hypophysectomized (removal o f pituitary gland) or sham lesioned prior to 
inescapable shock. In a shuttlebox, 24 h later, both lesioned and sham operated animals 
displayed learned helplessness. In a second experiment, intact animals were given high 
doses o f dexamethasone, a synthetic glucocorticoid receptor agonist, or saline. 
Dexamethasone activates the negative feedback to the HPA axis and blunts the 
production of CRF, ACTH and CORT during stress. Like the hypophysectomized 
animals, dexamethasone-treated rats developed learned helplessness comparable to saline 
controls (MacLennan et al., 1982). Only a few studies have utilized adrenalectomy and 
the results are mixed. Consistent with MacLennan and colleagues, Drugan, Paul & 
Crawley (1993) found that adrenalectomy did not interfere with the development of 
learned helplessness but others found a modest reduction in learned helplessness after 
bilateral adrenalectomy (Edwards, Harkens, Wright & Henn, 19901). These results 
suggest that CORT is not a necessary substrate of the learned helplessness effect on 
escape learning.
While CORT may not be the critical aspect o f learned helplessness, it is widely 
measured as an index of stressor severity. Inescapable and escapable shock produce 
nearly equal activation o f the HPA axis during the initial stress exposure (Maier et al., 
1986), however, helpless rats respond differently to a second stressor . A recurring theme 
of learned helplessness is that the initial stress experience alters responding to subsequent
1 E d w a r d s  e t  a l . ,  u s e  a  d i f f e r e n t  in d u c t io n  a n d  t e s t in g  d e s ig n  th a n  M a ie r  a n d  c o l l e a g u e s .  H o w e v e r ,  m u c h  
r e s e a r c h  h a s  u s e d  th e  a l te r n a t iv e  m e th o d  w it h  r e s u lt s  c o n s is t e n t  w it h  th e  m o d e l  b a s e d  o n  th e  p r o c e d u r e  o f  
M a ie r  e t  a l . ,  1 9 7 3 .
2 E s c a p e - y o k e  d i f f e r e n c e s  in  C O R T  a r e  fo u n d  in  s o m e  s h o c k  p a r a d ig m s  ( i . e .  S w e n s o n  &  V o g e l ,  1 9 8 3 ) .
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events. Johnson and colleagues intended to determine the possibility that rats treated with 
inescapable shock would show greater CORT response to a subsequent psychological 
(pedestal stress) or immune (lipopolysaccaride, LPS) challenge. They found that both 
LPS and pedestal stress evoked more rapid and greater CORT increase in stressed rats 
than in non-stressed controls (Johnson et al., 2002). It is clear that the HPA axis is 
affected by stress and responds differently to acute and chronic stressors. However,
CORT is the output o f a primitive neural mechanism that evolved to organize an 
organism’s physiological response to stress. This is likely true because virtually all 
stressful experiences activate the HPA axis, but not all produce learned helplessness. 
Endogenous Opioids
Initially, endogenous opioid substances were thought to be a critical factor in the 
learned helplessness model because exposure to intermittent shock produced an analgesia 
that persisted for 30-60 min after stress was terminated (Jackson et al, 1979). Rats 
exposed to 80 tail shocks display a bimodal pattern o f early and late stress-induced 
analgesia (SIA), but only the late SIA is blocked by the opiate antagonist naltrexone. Rats 
exposed to escapable shock display early opioid SIA but late SIA is non-opioid, 
suggesting that once the animal has learned control over the stress it somehow increases 
nociception (Drugan, Ader & Maier, 1985). As described above, MacLennan and 
colleagues (1982) uncovered an important relationship between the HPA axis and learned 
helplessness. Hypophysectomy and dexamethasone treatment completely eliminated the 
opioid dependent SIA produced by inescapable shock, but had no effect on escape 
performance. These results were replicated by Sutton, Fleshner, Mazzeo, Maier & 
Watkins (1994). Adrenalectomy completely eliminated the opioid analgesia produced by
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inescapable shock, but subjects with basal CORT replacement displayed SIA. Sutton et 
al., (1994) demonstrated that stress levels of CORT are not necessary for SIA and that the 
endogenous opioids that produce SIA originate in the brain, not the periphery.
Inescapable, but not escapable shock induced analgesia is cross tolerant to
morphine (Drugan, Grau, Maier, Madden, & Barchas, 1981) and potentiates morphine
analgesia (Grau, Hyson, Maier, Madden, & Barchas, 1981). Prior stress appears to cause
a hyper-analgesic response to a normally-ineffective dose o f morphine. Sutton, Grahn,
Wiertelak, Watkins & Maier (1997) tested a hypothetical circuit that could regulate these
opiate effects of inescapable shock. 5-HT neurons in the Dorsal Raphe Nucleus (DRN)
are under inhibitory control by both 5-HT ia autoreceptors (Tau & Auerback, 2003) and
local GABAergic interneurons (Harandi et al., 1987; Maier, Busch, Maswood, Grahn, &
Watkins, 1995). Endogenous opioids may act as disinhibitors, i.e. inhibiting the
GABAergic neurons that inhibit 5-HT cell bodies (Wang & Nakai, 1994). Naltrexone,
diazepam, and 8-OH-DPAT, administered locally in the DRN before inescapable shock,
completely eliminated the potentiation of morphine analgesia (Sutton et al., 1997) by
#
eliminating the role o f endogenous opioids, GABAergic neurons, and 5-HT neurons, 
respectively. It is clear from these studies that inescapable shock activates endogenous 
opioids and they appear to increase the activity of the DRN-5-HT system during stress 
and at a later exposure.
Corticotrophin Releasing Factor
Although CRF is the first step in the cascade of the HPA axis, it has only been 
appreciated in the stress response recently (compared to opioids and CORT). CRF was 
characterized in 1981 by Vale, Spiess, Rivier & Rivier as the putative hypothalamic
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trigger for ACTH and p-endorphin. CRF binds to two families o f G-protein linked 
receptors known as CRF-R1 and CRF-R2 (Bale & Vale, 2004). CRF immunoreactive 
fibers are found throughout the brain including the DRN (Swanson, Sawchenko, Rivier & 
Vale, 1983; Kirby, Rice & Valentino, 2000). CRF-R1 and -R2 receptors are both found in 
the DRN (Chalmers, Lovenberg, & De Souza, 1995). Because peripheral CORT is not 
essential for the learned helplessness effect, the possibility for brain-derived CRF to 
modify the activity o f central 5-HT has been explored by several researchers.
Lowry, Rodda, Lightman, & Ingram (2000) applied electrophysiological analysis 
to in vitro preparations of rat DRN. CRF enhanced the activity o f 5-HT neurons primarily 
in the caudal region of DRN. The effect o f CRF was potentiated in slices obtained from 
rats that received 5 days o f restraint stress (Lowry et al., 2000). The authors suggest that 
CRF may selectively modulate small groups of neurons in the DRN. These 
subpopulations have topographically organized projections that may allow CRF to 
mediate the physiology o f specific fear or anxiety behaviors (Kirby et al., 2000; Lowry et 
al., 2000; Lowry, 2002). Kirby and colleagues reported effects o f CRF on 5-HT activity 
and 5-HT release in some projections of the DRN using in vivo techniques. Price, Curtis, 
Kirby, Valentino and Lucki (1998) and Kirby et al., (2000) found that very low doses of 
CRF (0.3ng and 3.0ng) microinjected into the DRN significantly decreased the electrical 
activity of 5-HT neurons but a much higher dose (30ng) increased activity (Kirby et al., 
2000). Consistent with these findings, the low doses decreased extracellular 5-HT in the 
DRN while the high dose increased 5-HT in the DRN measured by in vivo microdialysis 
(Kirby et al., 2000). Summers et al. found the same pattern (2003). These effects appear 
to be mediated by the CRF-R1 receptor as the selective CRF-R1 antagonist antalarmin
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was able to block both the excitatory and inhibitory effects o f CRF. It is possible that 
CRF has significantly greater affinity for CRF-R1 receptors than the R2 family (Bale & 
Vale, 2004) which with these data suggest that inhibitory effect o f low doses o f CRF is 
on CRF-R1 receptors that may lie on GABAergic intemeurons (Kirby et al., 2000;
Roche, Commons, Peoples, & Valentino, 2003). However, it is also possible that the 
effects are mediated by CRF-R2 because mice lacking the CRF-R2 receptor are hyper- 
responsive to stress (Bale et al., 2000). The study of CRF receptors is still in its 
adolescence and therefore the actual role of CRF-R1 and -R 2  receptors is unclear (Bale 
& Vale, 2004).
Two recent reports have begun to characterize the interaction o f CRF within the 
DRN to mediate the effect of uncontrollable stress. In a series of elegant and exhaustive 
studies, Hammack, Richey, Schimd, LoPresti, Watkins and Maier (2002) demonstrated 
that the non-specific CRF antagonist D-Phe CRH( 12-41) injected into the DRN, but not a 
site adjacent to the DRN, blocked the effects of inescapable shock on fear and escape 
behavior. Further, CRF dose-dependently mimicked the effect o f inescapable shock on 
fear and escape behavior in unstressed rats. Hammack and colleagues’ careful work 
pinpointed the site o f action for CRF in the caudal region o f the DRN, because CRF 
injected to the rostral region was without effect. In a second report, Hammack and 
colleagues infused, into the caudal DRN, either a specific CRF-R1 antagonist or a 
specific CRF-R2 antagonist prior to exposure to inescapable shock. The CRF-R1 
antagonist was without effect while the CRF-R2 antagonist dose-dependently reduced the 
effects of inescapable shock on conditioned fear and escape behavior (Hammack et al., 
2003b). In addition, the selective CRF-R2 agonist Ucortin II was able to produce
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helplessness-like effects on fear and escape behavior without a stress exposure. These 
observations support the hypothesis that CRF-R1 inhibit 5-HT in the DRN while CRF-R2 
excite the DRN. A third report by Hammack, Pepin, DesMarteau, Watkins, & Maier 
(2003a) supports the possibility that CRF-R1 inhibits 5-HT transmission. Low doses of 
CRF, comparable to those used by Kirby et al., (2000), were able to block the 
helplessness-like effect produced by intra-DRN Ucortin II reported by Hammack et al., 
(2003b). In addition, the low dose o f CRF, administered before inescapable shock, 
blocked the traditional learned helplessness effect (Hammack et al., 2003a). These data 
suggest that the uncontrollable stress experience induces endogenous ligand-binding at 
the CRF-R2 site in the DRN; the ligand, however, may be one o f several peptides with 
affinity for CRF-R2 including CRF or one o f the Ucortins.
The Monoamines
It has long been recognized that dopamine (DA) and norepinephrine (NE) are 
involved in the stress response. DA and NE are distributed throughout the brain and 
likely organize neural activity during a stressful event. These neurotransmitters have been 
targets of many pharmacological treatments for stress-related disorders including anxiety 
and depression (Nestler et al., 2002) for the reasons that DA is the critical substrate of 
reward and NE is critical for arousal and motivation, behaviors affected by stress in both 
humans and animals.
Dopamine
The mesocortical and mesolimbic dopamine systems are comprised o f DA 
neurons from the ventral tegmental area that ascend to cortex through amygdala, nucleus 
accumbens, lateral septum, olfactory bulb, and terminate in the neocortex and the
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hippocampus (Cooper, Bloom & Roth, 1996). Inescapable footshock increased release of 
DA in the prefrontal cortex of rats (Thierry, Javoy, Glowinski, & Kety, 1968) and mice 
(Dunn, 1986). Dunn also examined DA turnover in other brain regions and found the 
most potent increase in the medial prefrontal cortex (mPFC) but also in hypothalamus, 
cingulate cortex, and brain stem. DA is capable o f either inhibitory or excitatory effects 
depending on binding to D1 postsynaptic receptors to enhance production of cyclic AMP 
(cAMP), or binding to D2 pre- and postsynaptic receptors to decrease production of 
cAMP (Cooper et al., 1996). Because mPFC appeared to be most affected by stress, much 
attention has been given to this site in the stress response.
The mesolimbic and mesocortical DA systems are considered to be the neural 
substrate o f rewarding stimuli and addictive drugs. Inescapable stress enhances the 
rewarding properties o f morphine in a conditioned place preference design (Will,
Watkins & Maier, 1998) but decreases acquisition o f an instrumental response for food 
(Rossellini, DeCola & Shapiro, 1982). Furthermore, the inbred, congenitally helpless rat 
is less motivated to work for sucrose than the congenitally non-helpless rat (Vollmayr, 
Bachteler, Vengeliene, Gass, Spanagel, & Flenn, 2004). These behavioral observations 
implicate central DA in the response to stress.
Microdialysis techniques have allowed for time-sampling o f DA activity in both 
the nucleus accumbens and the mPFC. Bland and colleagues have conducted several 
experiments to determine the effects of inescapable and escapable shock on the DA 
system. Escapable and inescapable shock increased extracellular DA at the onset of 
stress. During inescapable shock DA levels climbed to almost 300% of baseline while 
DA levels quickly returned to baseline during the escapable stress session (Bland,
31
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Hargrave, Pepin, Amat, Watkins, & Maier, 2003). A concomitant pattern of 5-HT was 
also observed in their studies. Because the DRN 5-HT system is crucial for the effects of 
inescapable shock on morphine conditioned place preference (Bland, Twining, Schmid, 
Der-Avakian, Watkins & Maier, 2004; Will et al., 2004), Bland and colleagues used the 
neurotoxin 5,7-dihydroxytryptamine to selectively denervate 5-HT to the mPFC prior to 
stress. To determine the possibility that 5-HT from the DRN was correlated with the 
mesolimbic DA system, animals were dialyzed in the nucleus accumbens for DA 24 h 
after stress and a single injection of morphine. Prior stress without 5-HT depletion 
potentiated the level of DA in nucleus accumbens in response to morphine, but 5-HT 
depleted rats showed no effect of prior stress (Bland, Shmid, Watkins & Maier, 2004).
These studies demonstrate that 5-HT from the DRN is capable o f modulating the 
inhibitory control over the VTA reward circuit that normally occurs in mPFC (Sesack, 
Carr, Omelchenko & Pinto, 2003). Indeed, the mPFC is located to receive input from all 
neurotransmitter systems during stress and therefore could organize, via descending 
inhibitory efferents, brainstem and limbic responses to stress. Amat and colleagues very 
clearly support this notion by demonstrating that temporary deactivation of mPFC 
eliminated the protective effects of coping, normally observed in the escapable stress 
condition, on behavior and on 5-HT activity within the DRN (Amat, Barratta, Paul,
Bland, Watkins & Maier, 2005). While DA is affected by stress, it is not likely the critical 
substrate o f learned helplessness because 6-hydroxydopamine lesions in prefrontal cortex 
did not affect the shuttlebox escape deficits produced by inescapable shock given 48 
hours earlier (Ravard, Camoy, Herve, Tassin, Thiebot, & Soubrie, 1990).
32
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
Norepinephrine
The pioneering work o f Weiss and colleagues on the effects o f stress 
controllability on behavioral and physiological measures resulted in an opponent 
hypothesis to the learned helplessness position. Instead o f learning to be helpless, Weiss, 
Stone & Harrell (1970) suggested that the stress experience altered the subsequent 
activity of rats that was produced by depletion o f central NE. NE neurons project widely 
to the brain from cell bodies within the locus coeruleus (LC). NE neurons rise through 
hypothalamus, amygdala, septum and terminate in many limbic and cortical regions 
including thalamus, basal ganglia, hippocampus olfactory bulb and all o f neocortex 
(Carlson, 2004). The classic view of the NE is that activation o f NE in the LC produces 
behavioral excitation through the a- and P-adrenergic receptors that are primarily 
excitatory; however, alpha2 receptors produce hyperpolarization. More specifically, NE 
appears to be important for modulating the salience o f stimuli, such as stressors (Aston- 
Jones & Cohen, 2005).
In addition to Weiss’s work, drugs that enhance the availability of NE by 
interfering with reuptake are able to block the learned helplessness effect (Sherman et al., 
1982). The effects of antidepressants are consistent with the observations of Weiss et al. 
(1981) that intermittent shock stress depletes NE from the LC and enhances this depletion 
when challenged with a second stressor such as a forced swim. Like many other effects of 
stress, animals that are able to cope during stress do not show the same pattern of 
depletion; in fact escapably stressed rats have more whole brain NE than yoked rats 
(Weiss et al., 1970). Depletion o f NE with the synthesis inhibitor FLA-63 produces an 
escape deficit that is comparable to the learned helplessness effect (Anisman, Remington
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& Sklar, 1979). Sherman & Petty (1980) were able to block the helplessness effect by 
injecting NE directly to the hippocampus. Further support that high levels NE protect 
against helplessness was reported by Petty, Kramer, Wilson and Chae (1993). Using in 
vivo microdialysis to determine the effect o f inescapable shock on NE in the ventral 
hippocampus, they found that rats with high levels of NE in hippocampus after stress did 
not become helpless (Petty et al., 1993). In addition, the authors found that after the 
shuttlebox test, K+ did not trigger as much NE release in previously shocked rats 
compared to the control group indicating that the stress treatment desensitized NE 
neurons. These studies, along with others (Nisenbaum, Zigmond, Sved, & Abercrombie, 
1991) suggest that NE plays an important protective role during stress and may be 
important for determining the most adaptive behavior (i.e. freezing, or fleeing) based on 
the external context.
Recently, Grahn and colleagues (2002) determined that NE release in the DRN 
during inescapable stress is sufficient for producing the learned helplessness effect. In 
their study, rats were infused with benoxantian, an ai antagonist prior to initial stress 
exposure. This treatment was sufficient to block the enhancement o f conditioned fear and 
escape deficits produced by inescapable shock (Grahn et al., 2002). The authors 
hypothesize that NE has an excitatory effect on 5-HT neurons within the DRN and 
therefore is consistent with the work by the groups of Weiss, Anisman and Petty 
described above.
Serotonin
5-HT is, by far, the most studied and understood neurotransmitter system that is 
involved in the learned helplessness response. In fact, in preparation o f this review it
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became apparent that the many brain systems that respond to stress affect 5-HT, 
indicating that 5-HT is a critical and common pathway responding to uncontrollable 
shock stress. 5-HT is distributed through the brain from cell bodies within the midbrain 
Raphe nuclei as well as the pineal gland.3 Like NE, 5-HT is a modulator of a number of 
behaviors that are affected by stress and several other variables including eating, sleep, 
arousal and pain. The 5-HT neurons within the DRN and the median Raphe nucleus 
(MRN) are activated by inescapable shock stress (Takase et al., 2004; 2005). Neurons 
from the DRN project through the medial forebrain bundle to the habenula, thalamus, 
hypothalamus, basal ganglia, hippocampus, amygdala, septum, olfactory bulb and all of 
neocortex. Neurons from the MRN project to these regions and also the cerebellum and 
dentate gyrus o f the hippocampus (reviewed by Jacobs & Azmiata, 1992). Several 5-HT 
receptor families are known (reviewed by Bames & Sharp, 1999) but the ones that are 
best characterized in the rat brain are, 5-HTi and 5-HT2. 5-HTia receptors appear to be 
most distributed throughout the CNS and serve two purposes: within the Raphe nuclei, 5- 
HT] a receptors are inhibitory somato-dendritic autoreceptors that very quickly adapt to 
stressful stimuli (Riad, Watkins, Doucet, Hamon, & Descarries, 2001) but outside of the 
Raphe, 5-HTiA receptors are postsynaptic G-protein-linked receptors negatively coupled 
to adenylate cyclase (Bames & Sharp, 1999). Because of its distribution, systemically 
injected ligands for 5-HT ia inhibit 5-HT tone at low doses but mimic 5-HT activity at 
higher doses.
In 1993, Maier and colleagues reported a very significant finding: lesions to the 
DRN eliminated the effects o f inescapable stress on both fear conditioning and escape
3 5 -H T  is  c o n c e n tr a te d  in  th e  p in e a l  g la n d  b u t its  r e le v a n c e  to  s tr e s s  i s  n o t  e n t ir e ly  c le a r  a n d  w i l l  th e r e fo r e  
b e  e x c lu d e d  fr o m  th e  p r e s e n t  d i s c u s s io n .
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behavior. This pivotal study opened the possibility to explain the partial effects of opiate 
drugs, stress hormones, GABAergic drugs, & NE on learned helplessness effects— all of 
these systems feedback to the 5-HT system. First I will review the effect of stress on 5- 
HT as indicated by several dependent measures including microdialysis and 
immunohistochemistry for the early immediate gene c-Fos, a marker o f cellular activity 
during stress (Kovacs, 1998).
Using in vivo microdialysis, inescapable shock stress was found to increase the 
extracellular levels o f 5-HT in the DRN (Maswood, Barter, Watkins & Maier, 1998), 
basolateral amygdala (Amat, Matus-Amat, Watkins & Maier, 1998a), mPFC (Bland et 
al., 2003; Petty et al., 1994) and ventral hippocampus (Amat, Matus-Amat, Watkins & 
Maier, 1998b). In every case, escapable shock only produced transient bursts of activity 
at the onset o f stress then rapidly returned to basal levels. One study found that escapable, 
but not inescapable, shock increased 5-HT turnover when measured in the periaqueductal 
grey (Amat et al., 1998b4). These data are supported by experiments utilizing c-Fos 
immunohistochemistry that found that inescapable stress selectively activates 5-HT 
neurons within the DRN (Grahn et al., 1999; Greenwood et al., 2003) and MRN (Takase 
et al., 2004; 2005). Escapable shock does induce c-Fos in the DRN but to a lesser extent 
than inescapable stress (Grahn et al., 1999).
While the Maier et al., 1993 study demonstrated that the serotonin system is 
necessary, as lesions to the DRN are sufficient to block the enhanced fear conditioning 
and escape deficit that follows inescapable stress, several additional studies have 
demonstrated that the DRN is the site of action for anxiogenic ligands for the
4 5 -H T  in  th e  P A G  m a y  in h ib i t  p r o d u c t io n  o f  e n d o g e n o u s  o p io d s  t h e r e b y  b lo c k i n g  th e  o p ia t e  S I A  a n d  
fu rth er  a c t iv a t io n  o f  5 - H T  n e u r o n s  in  th e  D R N  b y  e n d o r p h in s .
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GABA/benzodiazepine receptor, endogenous opioids, CRF, 5-HTja agonists, andNE. 
Furthermore, lesions to known excitatory afferents to the DRN extend the circuitry that 
activates the DRN to produce the effect. These studies will be reviewed below.
Drugs that act at the GABA/benzodiazepine receptor complex can potently alter 
the behavioral state of an organism. When given prior to inescapable shock, the 
benzodiazepine agonist, chlordiazepoxide, facilitates GABAergic transmission and 
eliminates the learned helplessness effect (Drugan, Ryan, Minor & Maier, 1984). In 
contrast, benzodiazepine inverse agonists, including the (3-carbolines FG-7142 (Drugan, 
Maier, Skolnick, Paul & Crawley, 1985) and methyl 6,7-dimethoxy-4-ethyl-p-carboline- 
3-carboxylate (DMCM; Maier et al., 1995) induce learned helpless-like behaviors in the 
absence o f stress. Maier et al., (1995) determined that the helplessness-like effect of 
DMCM on fear and shuttlebox escape was abolished in animals with DRN lesions. 
Therefore, p-carbolines could stimulate the DRN by reducing the inhibitory effect of 
endogenous binding at GABAa receptors on 5-HT neurons. Anxiety is clearly an 
important aspect of the learned helplessness effect (Drugan et al., 1984; 1985; Maier, 
1990; Maier & Watkins, 1998); hyperactivity o f the DRN/5-HT system and projection 
regions like the bed nucleus of the stria terminalis (BNST) and amygdala are most likely 
the neural substrate o f the anxiety. It is possible that the protective effect of systemic 
benzodiazepines on learned helplessness was due to facilitated inhibition of 5-HT 
neurons in the DRN by binding at GABAa receptors on 5-HT cell bodies. This action 
would prevent the hyperactivity o f the 5-HT system that is necessary for the learned 
helplessness effect.
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5-H T u receptors in the DRN are potent inhibitors o f serotonergic activity 
(Sprouse & Aghajanian, 1987) and therefore the release o f 5-HT during stress could lead 
to desensitization or downregulation o f 5-HT ia receptors. To my knowledge, some 
unpublished research supports this possibility (Short, Patel, Lee, & Tolarino, 2000; Maier 
unpublished observations reported in Greenwood et al 2003). Also in support o f this 
hypothesis, Maier, Grahn & Watkins (1995) demonstrated that the 5-HT ia receptor 
agonist, 8-OH-DPAT injected into the DRN before inescapable stress or before 
shuttlebox testing eliminated the learned helplessness effects. As described above, the 
DRN is an extrahypothalamic site of action for CRF. At high doses, CRF stimulates the 
activity of 5-HT neurons (Kirby et al., 2000; Lowry et al., 2000). Hammack and 
colleagues found that intra-DRN CRF mimicked the effects o f inescapable stress by 
activating 5-HT neurons and blocked helplessness with CRF antagonists (Hammack et 
al., 2002; 2003b). To further highlight the connection between CRF and 5-HT,
Hammack, Richey, Watkins & Maier (2004) produced excitotoxic lesions in the BNST5 
to disrupt a known CRF pathway that is involved in fear behaviors (e. g. Davis, Walker, 
& Lee, 1997). BNST lesions blocked the development o f conditioned fear and escape 
failure that normally follows inescapable shock stress (Hammack et al., 2004). The 
BNST may be able to modify the activity o f the DRN depending on the environmental 
context of stress, i.e. intermittent versus continuous or inescapable versus escapable 
conditions.
The DRN is also a site o f action for endogenous opioids. Opioids may disinhibit 
5-HT neurons by binding on GABAergic intemeurons. In addition, Maier and colleagues 
have demonstrated that excitatory input from NE (Grahn et al., 2002), the lateral
5 B N S T  p r o je c ts  C R F  im m u n o r e a c t iv e  a x o n s  to  th e  D R N  ( S w a n s o n ,  S a w c h e n k o ,  R iv ie r  &  V a le ,  1 9 9 3 ) .
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habenula (Amat, Sparks, Matus-Amat, Griggs, Watkins & Maier, 2001) nitric oxide and 
glutamate (Grahn, Watkins & Maier, 2000) provoke DRN-5-HT neurons to fire during 
stress. Taken together, these data clearly implicate the DRN-5-HT system as a necessary 
and sufficient neural substrate of the inescapable stress response. Maier and Watkins 
(1998) also review this research and posit the question: how does a rat exposed to 
escapable stress keep the DRN in check during the stress experience? Until recently, the 
best hypothesis was that an endogenous ligand for the GABA/benzodiazepine receptor 
complex was released during escapable stress but not inescapable stress (e.g. Drugan, 
Basile, Ha, & Ferland, 1994; Drugan & Holmes, 1991; Maier, Maswood, Grahn & 
Watkins, 1995). While this hypothesis remains tenable, Amat and colleagues (2005) 
recently discovered that temporary lesions to infralimbic/prelimbic medial prefrontal 
cortex (mPFC) eliminated the protective effect o f controllability. Intra-mPFC muscimol 
injections eliminated the differences normally observed between escapably and 
inescapably shocked rats on subsequent fear, shuttlebox escape, extracellular 5-HT levels 
in the DRN, and c-Fos induction in the DRN. The authors suggest that that descending 
glutamate neurons from the mPFC synapse on GABAergic intemeurons in the DRN to 
provide inhibition to 5-HT neurons. Close inspection of the dialysis data reveals that the 
attenuation of 5-HT occurs after approximately 20 trials of escapable stress (Amat et al., 
2005; Maswood et al., 1998). Amat and colleagues hypothesize that the mPFC is able to 
modify the lower-brain response to stress based on a contingency learned during escape. 
In contrast, Barata and colleagues were able to immunize rats to learned helplessness by 
intra-mPFC infusion o f picrotoxin to synthetically activate mPFC (Barratta, Watkins & 
Maier, 2005).
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Summary
The purpose o f this review was to describe the major neurochemical systems that 
appear to mediate the behavioral response to uncontrollable stress. Sensitization o f the 
DRN/5-HT is a consistent consequence of uncontrollable shock stress and has therefore 
been hypothesized to be the major substrate o f the learned helplessness effect (Amat et 
al., 1998a; 2005; Maier & Watkins, 1998). The DRN appears to be activated by several 
endogenous systems including CRF, opioids and NE. The hypothesized mechanism of 
action is one o f disinhibition via GABAergic neurons that generally provide inhibitory 
control of the 5-HT cell bodies in the DRN. Subsequent depolarization o f 5-HT soma 
causes neurotransmitter release in several projection regions including the amygdala, 
hippocampus, and mPFC. These projections may be the substrates for the increased fear, 
learning deficits, and benefits o f coping, respectively.
Hypothetical Role for Serotonin in the 
Intermittent Swim Stress Model 
The first goal o f this thesis was to determine if ISS altered learning in an 
instrumental escape test. After establishing that effect in the SET, the second goal was to 
determine what physiological mechanisms underlie the behaviors observed after ISS. ISS 
is a combination o f the stressor, water/swimming, from the behavioral despair model and 
the temporal parameters, 80, 5-second exposures on a VI-60 second schedule, o f the 
learned helplessness model. Rats that are exposed to ISS display two characteristics of 
behavioral depression including reduced activity in the FST and interference with escape 
learning (Christianson & Drugan, 2005 and Experiments 1A & B o f this thesis). While 
the neurobiological basis o f these ISS effects is unknown; much is known about the
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neural substrates o f behavioral despair and learned helplessness. The predominate 
hypothesis about these stress models is that acute stress causes a transient burst of activity 
in the 5-HT system, specifically in the neurons o f the Dorsal Raphe Nucleus (DRN), that 
is necessary for the development of behavioral depression (e. g., Grahn et al., 2002). This 
hypothesis is based on experiments that directly manipulate the DRN, record 5-HT 
activity, or observe behavior following acute administration of drugs acting on 5-HT.
Edwards, Johnson, Anderson, Turano & Henn (1986) reported that depletion o f 5- 
HT with the tryptophan hydroxylase inhibitor (the rate limiting enzyme for 5-HT 
synthesis) prevented the escape deficit produced by intermittent shock. Later, Maier et 
al., (1993) made a convincing case that 5-HT was a necessary component o f the stress 
response. In their study, electrolytic lesions to the DRN completely eliminated the effects 
of uncontrollable intermittent shock on fear conditioning and shuttle escape. Several 
studies have followed using more sensitive manipulations that involve direct 
microinjections into the DRN of drugs that reduce the activity o f 5-HT neurons. These 
experiments demonstrated that chlordiazepoxide, a benzodiazepine agonist, (Maier, 
Kalman & Grahn, 1994); 8-OH-DPAT, a 5-HT1A autoreceptor agonist, (Maier et al., 
1995); NMDA antagonists (Grahn et al., 2000); D-Phe CRF (12-41), a CRF antagonist 
(Hammack et al., 2002); and an a l  adrenergic antagonist, blocks excitatory input from 
LC (Grahn et al., 2002) given before initial stress exposure block the effects of 
intermittent shock on fear and escape learning.
Further support for the 5-HT hypothesis is gained from studies that quantified 5- 
HT activity during or immediately after stress. Continuous swim stress causes increased 
5-HT turnover measured by in vivo microdialysis in the DRN and in some target fields
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including the amygdala (Adell, Casanovas & Artigas, 1997), striatum (Kirby, Allen & 
Lucki, 1995), and mPFC (Jordan, Kramer, Zuchas & Petty, 1994). Intermittent shock 
stress produces a similar pattern of increased 5-HT turnover in the DRN (Maswood et al.,
1998) mPFC (Petty et al., 1994; Bland et al., 2004) and ventral hippocampus (Amat et al., 
1998b). Continuous swim (Roche et al., 2003) and intermittent shock (Grahn et al., 1999; 
Greenwood et al., 2003; Takase et al., 2004; 2005) increased staining of c-Fos in 5-HT 
immunoreactive neurons in the DRN. c-Fos is an immediate early gene that is an index of 
a neuron’s activity (Kovacs, 1998).
Drugs that increase the activity o f 5-HT produce some behavioral and 
physiological consequences that are similar to behavioral depression. Prior to stress 
exposure, administration o f 1-tryptophan, a 5-HT precursor, reduced the number of 
shocks (40 compared to 80) that were needed to induce learned helplessness (Brown, 
Rosellini, Samuels & Riley, 1982). Furthermore, administration o f the selective 5-HT 
reuptake inhibitor, fluoxetine, disrupted shuttlebox performance when administered 1 
hour before testing (Lucki & Nobler, 1985). Acute fluoxetine produces increases in 5-HT 
turnover in some of the same anatomical structures as inescapable shock and continuous 
swim; these regions include the DRN, frontal cortex (Rutter, Gundlah & Auerback,
1995), mPFC (Jordan, Kramer, Zukas, Moeller & Petty, 1994), striatum and 
hippocampus (Kreiss & Lucki, 1995).
In humans, fluoxetine is an antidepressant but is only effective after 3-4 weeks of 
treatment. In fact, fluoxetine has a paradoxical anxiogenic effect, called the “jitters”, that 
manifests with the first doses (Lipinski, Mallya, Zimmerman, & Pope, 1989). Acute 
fluoxetine is anxiogenic in animal models (Bagdy, Graf, Anheuer, Modos, & Kantor,
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2001; Handley & McBlane, 1993) and activates the neuroanatomical substrates of fear 
including the central nucleus of the amygdala and BNST (Salchner & Singewald, 2002). 
Fluoxetine also stimulates the HPA axis as indexed by increased blood levels of 
corticosterone (Duncan, Knapp, Carson, & Breese, 1998; Sera et al., 2001) and increased 
transcription o f CRF and CRF receptor genes in the hypothalamus (Torres, Horowitz 
Laflamme & Rivest, 1998). These findings support the hypothesis that an acute increase 
in 5-HT has stress-like effects on behavior and physiology.
Experimental Overview
This dissertation reports three experiments that intended to test the hypothesis that 
high levels of 5-HT during ISS would exacerbate the development o f ISS-increased 
immobility in the FST or that very low levels o f 5-HT during ISS would block that effect. 
In Experiment 2, fluoxetine was administered before ISS to systematically increase the 
post-synaptic levels o f 5-HT during stress. A dose-response curve was conducted using 
doses that are effective across several experimental paradigms in the literature. It was 
predicted that twenty-four hours later, rats treated with stress and fluoxetine would spend 
more time immobile in the FST than rats treated with stress, no stress, or fluoxetine 
alone. In the next experiment, tianeptine, a drug that was reported to enhance 5-HT 
uptake (Fattaccini, Bolonos-Jimenez, Gozlan & Hamon, 1990; Mennini, Mocaer, & 
Garattini, 1987; Witton, Sarna, O ’Connel & Curzon, 1991), was administered to reduce 
the levels of 5-HT in the synapse during stress. Tianeptine reduces the effect o f stress on 
HPA activity (Delbende, Contesse, Mocaer, Kamoun & Vaudy 1991) and blocks the 
detrimental effect of stress on hippocampal plasticity (Shakesby, Anwyl & Rowan,
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2002). It was predicted that twenty-four hours later, rats treated with stress and tianeptine 
would spend less time immobile than rats treated with stress alone.
After Experiment 3 was conducted, some investigators raised concern that 
tianeptine’s pharmacological effects were not specific to 5-HT and may act more directly 
on glutamatergic systems (Malagie, Deslandes, & Gardier, 2000; McEwen & Olie, 2005). 
It is therefore difficult to interpret the results of Experiment 2 with regards to 5-HT. 
Experiment 4 utilized a 5-HT synthesis inhibitor, para-chlorophenylalanine (PCPA), to 
deplete brain 5-HT before exposure to ISS. The methodology and results of these 
experiments is detailed in the following chapters.
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CHAPTER IV
EXPERIMENT TWO
The Forced Swim Test (FST) is the behavioral assay for immobility in the 
behavioral despair model. Previously, ISS (80, 5-sec trials, 15°C water) produced more 
immobility and less climbing than confinement in this test (Christianson & Drugan,
2005). Experiment 2 aimed to replicate and strengthen the ISS effect in the FST. As 
reviewed in Chapter I, stress appears to activate the 5-HT system; Experiment 2 tested 
the following hypothesis. Acute administration of the selective serotonin reuptake 
inhibitor fluoxetine (FLX) should increase the postsynaptic concentration of 5-HT 
released as a consequence o f stress. If ISS effects are mediated by transient release of 5- 
HT then FLX should enhance the development of ISS-induced immobility in the FST.
Method
Subjects
120 rats o f the same strain and source as Experiment 1 were used in this 
experiment. Housing conditions were the same for those used in Experiment 1 .The 
experimental procedure was reviewed and approved by the UNH IACUC (APPENDIX 
C).
Apparatus
ISS was administered in the same apparatus described above. 5-minute FSTs were 
conducted in clear plastic columns (20 cm dia.) filled with 29 cm of 23°C (+/-1°C) water
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(similar to those previously described for rats, Porsolt et al., 1977; Detke et al., 1995; 
Drugan et al., 1989). A video camera recorded a side view of the test for later analysis. 
Open field tests were conducted in an open-top square plywood chamber (120 X 120 X 
25 cm: L X W X H) painted with flat black enamel. Open field tests were video-taped 
using a wide-angel camera located directly over the center o f the arena. Path length was 
computed with HVS Field tracking hardware and software (Model VP200 Software 
Version 10/96; Hampton, UK).
Drugs
Fluoxetine was obtained from Spectrum Chemicals, prepared in 0.9 % saline, and 
administered intraperitonealy (i.p.) at 5, 10 or 20mg FLX per kg body weight. Control 
subjects received equal volume of 0.9% saline as vehicle.
Procedure
Rats were assigned to one o f 8 treatment groups in a 2 (Stress vs. Confinement) X 
4 (0 mg/kg, 5, mg/kg, 10 mg/kg, or 20 mg/kg FLX) completely randomized factorial 
design. Rats were allowed to acclimate to the vivarium for at least 7 days before 
beginning experimentation. On the first day o f the experiment rats were weighed and 
given an i.p. injection o f FLX. 45 min after injection (at a time when FLX induced CORT 
is peaking, Duncan et al., 1998) rats were exposed to either 80 trials o f ISS (15°C) or 
equal time in confinement. After stress, rats were towel-dried and warmed under heat 
lamps for 30 min or until rats resumed grooming.
24 h after the beginning o f stress, rats were given a 5-min FST. The tests were 
conducted in a similar fashion to that first described by Porsolt et al. (1977) but with 
deeper water to eliminate tail standing (Detke et al., 1995; Drugan et al., 1989) and a
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modified scoring technique that quantified immobile, swimming, and climbing behaviors. 
The modified technique employs a time-sampling procedure in which every 5 sec a rat is 
scored by an observer, blind to treatment, as immobile, the rat only makes the necessary 
movements to keep its head above water; swimming, the rat is active in the swim tank but 
is not struggling or climbing on the walls; and climbing, the rat is struggling against the 
wall of the tank and its forepaws are breaking the surface o f the water (Detke et al.,
1995). This modified technique is more sensitive to the antidepressant effects of 
serotonergic compounds than the traditional time-spent-immobile method proposed by 
Porsolt and colleagues (Cryan et al., 2002; 2005; Detke et al., 1995). Each FST was 
videotaped from the side so that two observers could simultaneously analyze behavior. 
Immobility, swimming and diving scores were recorded as the mean of each observer’s 
score. Data from 10 randomly selected FSTs were analyzed with Pearson’s r correlation 
to determine inter-rater-reliability. At the end of the 5 minute FST rats were towel-dried 
and placed in an open field and tracked via overhead video camera for 10 minutes. The 
open field test was conducted to confirm that active or inactive behaviors in the FST 
could not be attributed to a general change in spontaneous locomotor activity caused by 
either stress or drug treatment. Distance traveled (path length) during the open field test 
was determined with FIVS Maze video tracking software.
Results
Immobility
Mean counts o f immobility are presented in Figure 4, panel A. Inter-rater- 
reliability for immobility was high, r(8) = 0.973, p <  0.001. A 2 (stress or confinement)
X 4 (0, 5, 10, or 20 mg/kg FLX) between-subjects ANOVA identified a significant main
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effect o f stress, F{ 1, 88) = 9.614,/? < 0.01, indicating that ISS increased immobility 
despite FLX dose. Although there appears to be a trend that immobility increased with 
FLX dose, the main effect o f FLX did not reach significance, F(3, 88) = 1.854, p  -  0.14. 
No stress X FLX interaction was found, F(3, 88) = 0.575, p  = 0.634.
Swimming
Mean counts o f swimming are presented in Figure 4, panel B. Inter-rater- 
reliability for swimming was high, r{8) = 0.909, p  < 0.001. Swimming was analyzed in 
the same way as immobility. No significant effects were found for either stress, F (\, 88) 
= 1.551, p  = 0.216, or FLX, F(3, 88) = 0.730, p  = 0.537, or the interaction, F(3, 88) = 
0.867,/? = 0.462.
Climbing
Mean counts o f climbing are presented in Figure 4, panel C. Inter-rater-reliability 
for climbing was high, r(8) = 0.990,/? < 0.001. Climbing was analyzed in the same way 
as immobility. Stress significantly reduced climbing, F \ l ,  88) = 8.191,/? < 0.01 
regardless o f FLX dose. Although there appears to be a trend that climbing was reduced 
as FLX dose increased, the main effect o f FLX did not reach significance, F(3, 88) = 
2.164,/? = 0.098. The stress X FLX interaction was not significant, F(3, 88) = 0.513,/? = 
0.674.
Latency to 3 Immobile Blocks
Preliminary analysis o f immobility data revealed a clear trend that FLX caused 
rats to become immobile faster than saline. To objectively quantify this trend latency to 3 
consecutive trials o f immobility was computed for each rat by counting the number o f 5 
sec bins that were observed before three consecutive scores o f immobility. Mean
48
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
latencies are presented in Figure 4, panel D. FLX significantly reduced the latency to 
immobility, F(3, 85) = 5.252, p  = 0.002. However, Bonferoni post hoc tests found no 
significant pair-wise contrasts. No effect of stress or stress X FLX interaction was found, 
ps  > 0.05
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0 mg/kg 5mg/kg lOmg/kg 20mg/kg
Fluoxetine Fluoxetine
Figure 4. M ean (+/- SEM) scores for Immobility (A), Swimming (B) Climbing (C) a n d  
Latency to 15 sec o n d s  Immobile (D) in th e  5 m inute fo rced  swim test a fte r ISS a n d  
Fluoxetine trea tm en t. ISS significantly in c re ased  Immobility a n d  d e c re a s e d  Climbing, 
ps < 0.05. Fluoxetine significantly re d u c e d  la ten c y  to  15 sec o n d s  of continuous 
immobility, p  < 0.05. •  ISS, o C onfined
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Fluoxetine
Figure 5. M ean  (+/- SEM) p a th  length  (cm) during a  10 m inute o p e n  field test.
Fluoxetine d o se -d e p e n d e n tly  re d u c e d  p a th  length, p  < 0.05. •  ISS, o C onfined
Open Field
Mean path lengths (cm) from a 10 minute open field test are depicted in Figure 5. 
No main effect was found for stress, F( 1, 88) = 0.921, p  = 0.340. A significant main 
effect for FLX, F(3, 88) = 3.418,/? = 0.021, identified a trend that increasing doses of 
FLX reduced path length in the open field. Flowever, pair-wise Bonferonni post hoc tests 
did not identify any significant contrasts. No stress X FLX interaction was found, F(3,
88) = 0.137,;? = 0.938.
Discussion
The data from experiment 2 provide further evidence that exposure to ISS 
produces immobility in the FST. Some evidence that increasing 5-HT transmission 
enhances stress behaviors was observed in a trend that immobility increased and climbing 
decreased with FLX dose in both ISS and Confined groups. However, these behaviors 
could be attributed to a general FLX-induced reduction in locomotor behavior because 
FLX also reduced path length in the 10 min open field test. No effect was observed o f 
either stress or FLX on swimming behavior. This is in contrast to numerous reports
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reviewed by Cryan and colleagues (2002; 2005) that serotonergic manipulations affect 
swimming behavior to a greater extent than climbing. However, in our first report 
(Christianson & Drugan, 2005) and again here, ISS significantly reduced climbing 
behavior, regardless o f stress treatment. Cryan has argued that climbing behaviors in the 
FST reflect the activity o f norepinephrine (NE) such that increasing NE transmission with 
selective NE reuptake inhibitors like reboxetine reduce immobility by increasing 
climbing (Cryan, Page, & Lucki, 2002). In his studies, noradrenergic drugs do not affect 
swimming. The behavioral results observed here could suggest that ISS induced 
immobility is mediated by NE, rather than 5-HT.
A putative role for 5-HT could have been determined if FLX increased 
immobility only in ISS treated rats, however the trend that FLX increased immobility is 
present in both ISS and confined subjects. These data alone cannot confirm a role for 5- 
HT, therefore the following experiment attempted to reverse ISS-induced immobility 
with serotonin reuptake enhancer tianeptine, a drug that should reduce the synaptic 
activity of 5-HT during stress.
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CHAPTER V
EXPERIMENT THREE
If stress causes a transient surge in 5-HT activity, then manipulations that 
decrease the activity o f 5-HT neurons should attenuate the behavioral consequences of 
stress. Indeed, lesions to the DRN (Maier et al., 1993), and infusion o f benzodiazepines 
into the DRN (Maier et al., 1994), 8-OH-DPAT (Maier et al., 1995), CRF antagonists 
(Hammack et al., 2002), and a l  adrenergic antagonists (Grahn et al., 2002) block the 
behavioral effects of inescapable shock. In fact, the therapeutic effect o f exercise on 
learned helplessness can be attributed to reduced responsivity of DRN neurons during 
stress exposure (Greenwood et al., 2003). The preceding manipulations have reduced the 
ability of DRN neurons to fire during stress exposure. Experiment 3 will reduce the 
availability o f 5-HT in synapses without directly limiting DRN neurons from responding 
to stress. The 5-HT uptake enhancer tianeptine was administered before 100 trials ISS. 
100 trials were used to produce a robust ISS-immobility (as 100 trials ISS produced a 
more robust ISS effect than 80 trials, Experiment IB) and to prevent a failure to find drug 
effects because o f a floor effect. Acute administration of tianeptine should decrease the 
synaptic levels of 5-HT during stress; therefore tianeptine should reduce the development 
of swim-stress induced inactivity in the FST.
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Method
Subjects
72 rats o f the same strain and source were used in this experiment. The 
experimental procedure was reviewed and approved by the UNH IACUC (APPENDIX 
C).
Apparatus
ISS, FSTs and open field tests were administered in the same apparatus described 
for Experiments 1 and 2.
Drugs
Tianeptine sodium salt was obtained from Sigma-Aldrich and prepared in 0.9 % 
saline and administered i.p. at 5 and 10 mg tianeptine per kg body weight. This dose 
range was selected because lOmg/kg tianeptine was the largest dose found in the 
literature and blocked restraint stress induced increase in plasma CORT (Delbende et al., 
1991) Control subjects received equal volume of 0.9% saline as vehicle.
Procedure
Rats were assigned to one o f 6 treatment groups in a 2 (Stress vs. Confinement) X 
3 (0 mg/kg, 5, mg/kg, 10 mg/kg tianeptine) completely randomized factorial design. Rats 
were allowed to acclimate to the vivarium for at least 7 days before beginning 
experimentation. On the first day o f the experiment rats were weighed and given an i.p. 
injection of tianeptine prepared in 0.9% saline. 45 minutes after injection, rats were 
exposed to either 100 trials of ISS (15°C) or equal time in confinement. After stress rats 
were towel-dried and warmed under heat lamps for 30 minutes or until rats resumed 
grooming. 24 hours after the beginning o f stress, rats were tested for immobility in a 5
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minute FST as described above. After the FST, all rats were immediately transferred to 
the open field and videotaped for 10 minutes. FST and Open Field videos were analyzed 
in the same method as Experiment 2.
Results
Immobility
Mean counts o f  immobility are presented in Figure 6, panel A. Inter-rater- 
reliability for immobility was high, r(8) = 0.974, p  < 0.001. A 2 (stress or confinement)
X 3 (0, 5, or 10 mg/kg tianeptine) between-subjects ANOVA identified a significant main 
effect o f stress, F( 1, 55) = 15.02,/? < 0.001, indicating that ISS increased immobility 
despite tianeptine dose. No effect o f tianeptine was observed, F(2, 55) = 0.05,/? = 0.951. 
No stress X tianeptine interaction was found, F(2, 55) = 0.122,/? = 0.887.
Swimming
Mean counts o f  swimming are presented in Figure 6, panel B. Inter-rater- 
reliability for swimming was high, r(8) = 0.906,/? < 0.001. Swimming was analyzed in 
the same way as immobility. No significant effects were found for either stress, F( 1, 55)
= 0.125,/? = 0.725, or tianeptine, F(2, 55) = 0.029,/? = 0.972, or the interaction, F(2, 55)
= 0.271 ,/? = 0.764.
Climbing
Mean counts o f climbing are presented in Figure 6, panel C. Inter-rater-reliability 
for climbing was high, r(8) = 0.993,/? < 0.001. Climbing was analyzed in the same way 
as immobility. Stress significantly reduced climbing, F ( l, 55) = 14.210,/? < 0.001 
regardless o f tianeptine dose. The main effect o f tianeptine was not significant, F(2, 5) =
5 4
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0.048,p  = 0.953. The stress X tianeptine interaction was not significant, F{2, 55) = 0208, 
p  = 0.813.
Latency to 3 Immobile Blocks
. Latency to 3 consecutive trials of immobility was computed for each rat in the 
same way as experiments 2 and is presented in Figure 6, panel D. No effects o f stress, 
tianeptine, or stress X tianeptine interaction were found, ps > 0.05.
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Tianeptine Tianeptine
Figure 6. M ean  (+/- SEM) scores for Immobility (A), Swimming (B) Climbing (C) a n d  
Latency to  15 sec o n d s  Immobile (D) in th e  5 m inute fo rced  swim test. ISS significantly 
in c reased  Immobility a n d  d e c re a s e d  Climbing in th e  FST, p s < 0.05. Neither stress nor 
tianep tine  a lte red  swimming or la ten cy  to  immobility. •  ISS, o C onfined
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Open Field
Mean path lengths (cm) from a 10 minute open field test are depicted in Figure 7. 
No main effect was found for stress, 7*1(1, 56) = 0.828, p  = 0.367, tianeptine, F(2, 56) = 






5 mg/kg 10 mg/kg0 mg/kg
Tianeptine
Figure 7. M ean  (+/-SEM) p a th  length  (cm) during a  10 m inute o p e n  field test. Neither 
stress nor tian ep tin e  a lte red  p a th  length. •  ISS, o C onfined
Discussion
As in Experiment 2, the results indicate that ISS increases time spent immobile 
and reduces climbing in the FST. However, the purported serotonin reuptake enhancer 
tianeptine had no impact on these effects. It seems acceptable then, to conclude from 
Experiments 2 and 3 that 5-HT does not play a significant role in ISS induced immobility 
because FLX did not worsen, and tianeptine did not improve the performance of stressed 
rats in the FST. While the efficacy of tianeptine to block some o f the effects of 
uncontrollable stressors is clear (i.e. Conrad, Galea, Kuroda & McEwen, 1996; Delbend 
et al., 1991; Shakesby et al., 2002; Whitton et al, 1991), the role o f 5-HT uptake in its 
effect has recently been criticized. In fact, McEwen & Olie (2005) argue that tianeptine
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alters glutamatergic transmission and that appears to be the therapeutic mechanism for 
the drug. This possibility makes the role o f 5-HT in the ISS paradigm difficult to discern. 
On the one hand, tianeptine is an effective antidepressant and has been shown to block 
acute stress effects in similar doses, but on the other hand, tianeptine may not act directly 
on 5-HT. Consequently, the results are provocative because tianeptine did not affect 
immobility, but discouraging because this experiment did not address the empirical * 
question regarding the role o f 5-HT on ISS-induced immobility. Despite questions 
regarding tianeptine’s specificity to 5-HT uptake, the data from Experiments 2 and 3 
suggest that 5-HT is not a critical mediator o f the ISS phenomenon. The hypothermia that 
is produced by ISS (Levay et al., 2006) could recruit non-5-HT systems and therefore 
overshadow any role that 5-HT would play in behavior. Pre- and post-stress temperature 
was recorded in Experiment 4 to determine the degree of hypothermia produced by 100 
trials of ISS.
It is now necessary to find a treatment that will reduce the impact o f 5-HT during 
stress and can provide a definitive answer to the question concerning the role of 5-HT in 
ISS induced immobility. The tryptophan hydroxylase inhibitor para-chlorophenylalanine 
(PCPA) causes a selective depletion of brain 5-HT with minimal behavioral 
consequences (Koe & Weisman, 1966). Furthermore, PCPA has been used to reverse the 
learned helplessness effect (Edwards et al., 1988) and is without effect in the modified 
FST (Page, Detke, Dalvi, Kirby & Lucki, 1999). In Experiment 4, PCPA was 
administered prior to stress to give a definitive answer to the question: Is 5-HT important 
to the ISS-induced immobility?
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CHAPTER VI
EXPERIMENT FOUR
While direct inactivation o f 5-HT neurons that innervate the forebrain, such as 
DRN lesions, effectively block the effect o f electric shock on fear and escape learning 
(Maier et al., 1993) 5-HT depletion by daily administration of the tryptophan hydroxylase 
inhibitor para-chlorophenylalanine (PCPA) has been shown to reverse the learning deficit 
in helpless rats (Edwards et al, 1986) and also reversed shock-reduced climbing in a 
forced swimming test (Plaznik, Tamborska, Hauptmann, Bidzinski, & Kostowski, 1988). 
Given that Experiments 2 and 3 provide little empirical support for a 5-HT role in the ISS 
phenomenon, and that systemic administration of PCPA is more feasible than DRN 
lesions, PCPA was selected to further test the hypothesis stated in Experiment 3.
A range o f PCPA doses were found to effectively deplete brain serotonin: 
500mg/kg/2days = 92% reduction (Dringenberg, Hargraves, Baker, Cooley, & 
Vanderwolf, 1995) 74% reduction (Reader, 1982); 160mg/kg/3days = 89% reduction 
(Prinssen, Assie, Koek, & Kleven, 2002), 100mg/kg/3days = 50% reduction (Edwards et 
al., 1986) and 150mg/kg/lday = 93% reduction in a cortex sample (Page et al., 1999). 
Behaviorally effective doses o f PCPA were found at the low dose o f 100mg/kg/3 days 
(Edwards et al., 1986; Plaznik et al., 1988). It appeared that chronic administration 
produced the most lasting depletion, up to 5 days after last injection (Valzelli, Bernasconi 
& Dalessandro, 1983), and that doses between 150mg/kg and 500mg/kg produced the
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greatest reduction in brain 5-HT; therefore, a 200mg/kg/3days schedule was selected for 
this study to achieve approximately 90% 5-HT depletion. Therefore, rats were treated 
with either PCPA or saline for three days prior to ISS or confinement on the fourth day 
followed by a 5 minute FST on the fifth day. If  5-HT is a necessary substrate of ISS- 
induced immobility, then the 5-HT depletion caused by PCPA should reduce the 
prevalence o f immobile behaviors compared to saline treated ISS rats. Given the possible 
influence o f hypothermia on non-5-HT brain systems, colonic temperature was observed 




44 rats of the same strain and source previously described were used in this 
experiment. The UNH IACUC reviewed and approved this protocol (APPENDIX D). 
Apparatus
ISS, FSTs and open field tests were administered in the same apparatus described 
for Experiments 1, 2 and 3. Colonic temperature was recorded using a Yellow Springs rat 
rectal probe (Yellow Springs Instruments, Yellow Springs, OH, Model No. 400) and a 
Fisher Digital Thermometer (Fisher Scientific Instruments, Model No. 057803). A ring of 
paper was built-up around the probe to help maintain a consistent insertion depth to 2.2 
mm.
Drugs
DL-p-Chlorophenylalanine methyl ester hydrochloride was obtained from 
Research Organics, prepared in 0.9% Saline and administered i.p. at 200mg/kg PCPA per
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Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
kg body weight. Control subjects received equal volume of 0.9% saline as vehicle. 
Procedure
Rats were assigned to one o f 4 treatment groups in a 2 (Stress vs. Confinement) X 
2 (0 or 200 mg/kg PCPA) completely randomized factorial design. Rats were allowed to 
acclimate to the vivarium for at least 7 days before beginning experimentation. On the 
first three days o f the experiment rats were weighed and given i.p. injections o f PCPA or 
saline. On the fourth day, each rat was wrapped in a cotton towel and a temperature probe 
coated in petroleum jelly was inserted 2.2 mm into the rectum for approximately 15 sec 
to obtain pre-stress colonic temperature. Then, rats were exposed to either 100 trials of 
ISS or equal time in confinement. Upon termination of the stress session, post-stress 
colonic temperature was obtained using the method described above. Immediately, rats 
were towel-dried and placed under heat lamps for 30 minutes or until rats resumed 
grooming. 24 h after the beginning o f stress, rats were tested in a 5 minute FST as 
described in Experiment 2. After the FST, all rats were immediately transferred to the 
open field for 10 minutes. FST and open field tests were analyzed in the same fashion as 
Experiments 2 and 3.
Results
Immobility
Mean counts o f immobility are presented in Figure 8, panel A. One rat in the ISS- 
PCPA group was removed from the experiment because it was not able to complete 100 
trials of stress, therefore in all subsequent analyses n=  11/group except ISS-PCPA where 
n = 10. Inter-rater-reliability for immobility was high, r(8) = 0.983, p  < 0.001. A 2 (stress 
or confinement) X 2 (Saline or 200mg/kg/3days PCPA) between-subjects ANOVA
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identified no significant main effects for stress, F( 1, 39) = 0.620, p  = 0.436, PCPA F( 1, 
39) = 4.065./? = 0.051or stress X PCPA interaction, F ( l, 39) = 0.387,/? = 0.538. 
Swimming
Mean counts o f swimming are presented in Figure 8, panel B. Inter-rater- 
reliability for swimming was high, r{8) = 0.866, p  = 0.001. Swimming was analyzed in 
the same way as immobility. No significant main effects were found for stress, F (l, 39) = 
1.031,/? = 0.316, or PCPA, F( 1, 39) = 1.884,/? = 0.178. However a significant stress X 
PCPA interaction was found, F( 1, 39) = 5.533 ,p  = 0.024. A post hoc stress X PCPA X 
treatment contrast confirmed that ISS significantly reduced swimming in the saline 
condition, F ( l, 39) = 5.812,/? = 0.021.
Climbing
Mean counts o f climbing are presented in Figure 8, panel C. Inter-rater-reliability 
for immobility was high, r(8) = 0.975, p  < 0.001. Climbing was analyzed in the same 
way as immobility. No significant effects were found: stress, F ( l ,  39) = 0.1992,/? = 
0.658; PCPA, F( 1, 39) = 2.705,/? = 0.108; or stress X PCPA interaction, F (l, 39) = 
0.1884,/? = 0.667.
Latency to 3 Immobile Blocks
Latency to 3 consecutive trials o f immobility was computed for each rat in the 
same way as experiments 2 and 3 and is presented in Figure 8, panel D. Stress appeared 
to reduce the latency to immobility, however the trend was not significant, F( 1, 39) = 
1.675,/? = 0.203. No effects were found for PCPA, F ( l ,  39) = 0.422,/? = 0.520, or stress 
X PCPA interaction, F( 1, 39) = 0.085,/? = 0.772.
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Figure 8. M ean  (+/-SEM) scores for Immobility (A), Swimming (B) Climbing (C) a n d  
Latency to  15 sec o n d s  Immobile (D) in th e  5 m inute fo rced  swim test. *ISS significantly 
re d u c e d  swimming in th e  saline condition, p  = 0.021. •  ISS, o C onfined
Open Field
Mean path lengths (cm) from a 10 minute open field test are depicted in Figure 9. 
No significant effects were found for stress, F ( l, 39) = 0.989, p  = 0.326; PCPA, F (l, 39) 
= 0.657, p  = 0.422; or stress X PCPA interaction, F( 1, 39) = 2.810,/? = 0.102.
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Figure 9. M ean  (+/- SEM) p a th  length  (cm) during a  10 m inute o p e n  field test. 




Figure 10. M ean  (+/- SEM) T a  (°C) a fte r 100 trials of ISS. ISS re d u c e d  T a ,  p  < 0.01. 
•  ISS, o C onfined
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Colonic Temperature
Temperature change scores (Ta) were computed as Ta = (colonic temperature after 
stress or confinement) -  (colonic temperature before stress or confinement). 7a was not 
computed for one rat in each treatment group because of a thermometer malfunction, 
therefore n = 10 in all groups except for ISS-PCPA where n = 9). Mean Ta are depicted in 
Figure 10. 100 trials o f ISS significantly lowered colonic temperature by approximately 
15°C, FIT, 35) = 537.1,/? < 0.001. PCPA did not affect this pattern, F ( l,  35) = 1.619,/? = 
0.212 and there was no stress X PCPA interaction, F{ 1, 35) = 0.190,/? = 0.666.
Discussion
Daily administration o f PCPA did not alter ISS induced immobility. The 
phenomenological finding that ISS increases immobility and decreases climbing is not 
present in these data; this is unfortunate because these effects appeared to be robust in 
three separate experiments. It is likely that the handling and housing conditions unique to 
experiment 4 can account for this reduced effect; specifically, single-housing, daily 
weighing and i.p injection for three days prior to ISS may have attenuated the behavioral 
response to stress. Despite a failure to replicate the primary stress effect on immobility 
and climbing, ISS significantly decreased swimming in the saline condition. This result is 
consistent with the phenomenon o f ISS-induced inactivity. O f the experiments included 
in this dissertation, only Experiment 3 revealed a robust ISS-induced immobility under 
saline conditions. While main-effects for stress were observed on immobility and 
climbing in Experiment 2, there appears to be considerable variability in confined-saline 
immobility. In three o f four experiments conducted in our lab using the FST, confined 
animals spend, on average, 30 counts o f immobility. In Experiment 2, confined-saline
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treated rats spent, on average 37 counts of immobility. It is possible that the injection 
procedure or perhaps an unusual stock of rats used in Experiment 2 raised basal levels of 
immobility, and therefore reduced the appearance of a stress effect. In contrast, the 
immobility average for confined-saline treated rats in Experiment 4 is within the range 
commonly observed for control subjects in our hands, the lack o f stress effect appears to 
be due to an attenuated immobility in the ISS-saline group. The handling and housing 
procedure used in this experiment may have caused a general reduction in immobility, 
regardless o f stress or PCPA treatment. If the immobility observed after ISS reflects some 
sort o f learning, the warming treatment, 30 min under incandescent lamps, after ISS 
could interfere with hippocampal processes (Nakamura, Miyamoto, Sumitani, Negi,
Itano, & Nagao, 2003) and, perhaps, block memory formation about the inescapable 
stress experience. Future experiments may require modification to enhance the 
phenomenological effect that ISS-induced immobility under a variety o f handling, 
housing, and injection conditions.
PCPA was without effect on all dependent measures. Consistent with the results 
of Experiments 2 and 3, there is not substantial evidence that 5-HT is a critical mediator 
of the ISS phenomenon. To be sure, it is impossible to rule out 5-HT based strictly on 
these observations without verifying that the pharmacological tools used here did, in fact, 
increase or reduce 5-HT levels with post mortem analysis o f 5-HT content in brain tissue. 
Furthermore, hypothermic conditions reduce metabolic processes in the brain including 
glucose and oxygen metabolic rates (Erecinska, Thoresen, & Silver, 2003). To my 
knowledge, the effect o f hypothermia on elimination and pharmacokinetics has not been 
studied for fluoxetine, tianeptine, or PCPA; however, the hypothermic conditions in these
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studies may have slowed the metabolic elimination o f these drugs and altered their 
pharmacokinetic profiles. Okuda, Saito, Miyazaki, & Kuriyama, (1986) found increased 
concentration of 5-HIAA, the primary metabolite o f 5-HT in some brain regions 
following hypothermia in the rat. Accelerated breakdown o f 5-HT during ISS could 
explain why the serotonergic manipulations implemented in these studies were without 
effect. Future studies with warm water would eliminate this potential confound.
Observation o f TA extended the observations o f Drugan et al., (2005) and Levay et 
al., (2006) to the 100 trial ISS paradigm in 15°C water. Drugan et al., used a triadic 
design and reported that 80 swim trials in 25°C and 20°C caused core body temperature 
reductions of approximately -5°C and -7°C, respectively. However, 80, 5 sec swim trials 
in 15°C water cause core body temperature reduction o f 12°C (Levay et al., 2006). 100 
trials in 15°C water produced an approximately 15°C reduction in colonic temperature, a 
far more severe hypothermia than previously observed.6 The addition o f 20 trials in the 
current paradigm may account for the slightly greater hypothermia compared to the 80 
trial stress. Levay et al., observed that swim stressed rats recovered body temperature to 
baseline 100 min after removal from swimming. After recovery, interestingly, stressed 
animals displayed hyperthermia for 5 h. Hypothermia is one characteristic of the ISS 
paradigm that makes it different than intermittent shock which causes a hyperthermic 
response (Deak et al., 1997). Although hyperthermia is observed in ISS treated rats after 
core body temperature returned to baseline, the hypothermic experience makes ISS 
qualitatively different than shock. The potential for ISS to cause thermogenesis that
6 D r u g a n  e t  a l . , ( 2 0 0 5 )  a n d  L e v a y  e t  a l . ,  ( 2 0 0 6 )  r e c o r d e d  c o r e  b o d y  te m p e r a tu r e  w i t h  b io t e le m e t r y  d e v ic e s  
s u r g ic a l ly  im p la n te d  in  th e  a b d o m in a l  c a v i ty .  C o lo n ic  te m p e r a tu r e , a s  m e a s u r e d  h e r e ,  m a y  b e  m o r e  
s u s c e p t ib le  r e s p o n s e  to  c o ld .
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recruits non-5-HT systems is discussed in the following chapter and could explain why 5- 
HT does not appear to be an important mediator of the ISS phenomenon.
In designing the ISS paradigm it was never the intention to study hypothermia 
stress. It is likely that the severe hypothermia produced in the current paradigm masks the 
more subtle psychological aspects of stress related to uncontrollability and predictability. 
We have demonstrated that ISS, but not escapable swim increases immobility after swim 
in 30°C water without producing a significant Th (Drugan et al., 2005). Therefore, future 
studies with ISS should use warmer water and, perhaps, more trials to eliminate the 
confounding influence of hypothermia and to focus on the psychological parameters of 
swim stress.
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CHAPTER VII
GENERAL DISCUSSION
The results o f the experiments reported in this thesis add to the literature on 
inescapable stress, but introduce new questions to be addressed by future research on ISS. 
These experiments demonstrate that ISS produces a syndrome o f behaviors that may 
resemble some symptoms of depression including learning interference in an instrumental 
escape task, the SET, and by immobility in the 5-min FST. Because o f the consistency 
within the literature that implicates 5-HT in the behavioral consequences of other 
intermittent stressors in animal models and in human depression, these experiments 
intended to determine a causal role for the 5-HT system in the ISS effect on immobility. 
However, the data do not support this possibility. There is some indication that acute 
FLX increased immobility in the FST and reduced path length in the open field, but it did 
not enhance the effect of stress. It is necessary to resolve the, now apparent, contrast 
between the serotonergic basis o f intermittent shock induced behaviors and the non- 
serotonergic intermittent swim induced behaviors. There are two important differences 
between shock and swim stress: a) intermittent shock produces hyperthermia (Deak et al., 
1997; Weiss et al., 1981) while intermittent swim produces hypothermia followed by 
hyperthermia (Experiment 4 and Drugan et al., 2005; Levay et al., 2006). b) The stress 
induction and test procedures o f intermittent shock and swim impose different physical 
demands on the rat. Specifically, shock is delivered in restraint and tested in a learning
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task where there is little physical activity while swimming causes a great deal of physical 
activity; these behavioral differences may have distinct neurochemical and ethological 
components. First, it is necessary to describe how ISS induction produces a very unique 
stress experience compared to either intermittent shock or continuous swim. Then, non- 
serotonergic physiological systems will be suggested as potential mediators o f the ISS 
phenomenon.
Figure 11 depicts some dimensions o f the stress experience that are characteristic 
of intermittent shock, continuous swim and ISS. During intermittent shock the organism 
is subjected to brief, painful and unpredictable stress in restraint. Continuous swim, on 
the other hand, involves a continuous, physically demanding stress that also causes mild 
hypothermia. Drugan et al., hypothesized that in-between shocks animals develop fear 
because the next shock is unpredictable and uncontrollable (Drugan et al., 1984). It seems 
unlikely that anticipatory fear is a psychological component of continuous swim because 
the rat is continually exposed to a life-threatening stress. In the continuous swim, the rat’s 
behavior transitions from a highly active state where escape oriented behaviors, including 
climbing and diving predominate to a passive state characterized by behavioral 
immobility. Anecdotally, the same transition from active to passive behaviors is readily 
observed during the ISS session. However, ISS is quite different from continuous stress 
for three reasons: 1) brief, intermittent swims in the ISS procedure allow for the 
possibility of a fearful state, although the sound of the lift-motor in the apparatus may 
signal the onset o f the next swim; 2) ISS is conducted in colder water than continuous 
swim, 23°C vs. 15°C respectively; 3) the total time in the water after 100, 5 sec trials is 
only 6 min 40 sec compared to 15 min o f continuous swim. Finally, the severe
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hypothermia produced by ISS (Experiment 4 and Levay et al., 2006) makes it 
qualitatively distinct from both intermittent shock and continuous swim. At this point in 
our research, the significance of the hypothermic response cannot be understated because 
rats stay in the hypothermic state for over 100 min after the termination o f stress which is 
followed by mild hyperthermia for up to 5 h (Levay et al., 2006). The behavioral 
















Figure 11. G raphic representation of some characteristics of Intermittent Shock, Continuous 
Swim and ISS (top-to-bottom , respectively). Bars symbolize the time that the organism is 
exposed to the physical stressor and the hashed line indicates a  time-course of hypothermia  
(expressed in arbitrary units). It is apparen t that ISS produces a  stress experience that is quite 
different from the intermittent shock and continuous swim paradigm s.
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C7B
Hypothermia
ISS is an aversive experience for at least two reasons: forced exposure to physical 
activity and exposure to a cold environment. Cold water was first introduced to the ISS 
protocol because exposure to 23°C stress did not appear to produce robust behavioral 
effects (Brown et al., 2001; Christianson master’s thesis, 2002). Reducing water 
temperature to 15°C and increasing the duration o f the stress session produced a marked 
increase in the behavioral depression observed in the forced swim test and in the SET 
(Christianson & Drugan, 2005). It is possible that these effects are due to hypothermia. 
Several investigators have produced immobility by mere reduction in body temperature 
(Rauch & Lieberman, 1990; Taltavull, Chefer, Shippenberg & Kiyatkin, 2003) while 
others fail to find the classic “behavioral despair” effect after continuous swim in warm, 
35°C (Arai, Tsuyuki, Shiomoto, Satoh & Otomo, 2000) or 37°C water (Taltavull et al., 
2003). In fact, Arai and colleagues found a negative correlation between core body 
temperature and immobility. The “cold” conditions implemented by these researchers are 
comparable to those reported in many behavioral despair experiments (Aria et al., 2000; 
Porsolt, Deniel & Jalfre, 1979). These continuous swim conditions produce hypothermia 
that is comparable to that found after 80 trials o f ISS in an escape-yoke paradigm in 20°C 
water (TA -6°C; Drugan et al., 2005). However, the ISS procedure used here, 100, 5 sec 
trials, produces a far greater hypothermia, as much as T \ -15°C.
Conditioned hypothermia has been observed as a classically conditioned response 
in rats given hypothermia-evoking drugs, such as morphine, in distinct environments 
(Eikelbloom & Stewart, 1981). While no report of conditioned hypothermia to distinct 
cold environments was found in the literature, it is possible that the hypothermia
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produced during ISS is conditioned to the context and reappears in the FST to facilitate 
immobility. To resolve this issue body temperature response to a brief exposure to the 
FST could illuminate this possibility. Cold adaptation or cold tolerance has been 
observed in a variety o f species and is best characterized as habituation to repeated cold 
exposure (LeBlanc, 1992). 100 trials of ISS could be sufficient for rats to habituate to a 
cold swim environment and blunt behavioral responses, including climbing or struggling, 
in the FST. Hypothermia could account for the immobility observed in the current 
experiments; however, this is unlikely because inescapable ISS in 30°C, which did not 
significantly alter body temperature, produced immobility while escapable ISS did not 
(Drugan et al., 2005). That finding supports the possibility that psychological aspects of 
ISS, such as controllability, contribute to the behavioral depression found in the FST.
On the other hand, hypothermia may play a more important role in the effect o f 
ISS on escape learning. Hypothermia has been used in many laboratories to induce 
anterograde amnesia for classically conditioned memories such as conditioned taste 
aversions (Misanin et al., 2002; Santucci & Riccio, 1986) and retrograde amnesia for a 
passive avoidance task (Hamm, 1981). Hypothermia also impaired acquisition and 
retention in the Morris Water Maze test of spatial cognition (Panakhova, Bruesova & 
Bures; 1984; Rauch, Welch & Gallego, 1989). The amnestic effects o f hypothermia are 
likely due to slowed metabolism in brain that could weaken associations made between 
stimuli in classically conditioned learning or between stimulus and response in 
instrumental learning. This has been described as a time-dilation effect that appears to 
disrupt the temporal contiguity o f stimuli (i.e. Misanin et al, 2002). The interference of 
instrumental escape behavior observed in the SET and in the Morris Water Maze
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(Christianson, VanHoogenstyn & Drugan, unpublished observations) therefore, could be 
the result o f hypothermia. This possibility could be empirically resolved by replicating 
the methods o f Experiment 1 under stress conditions that do not produce hypothermia.
If  the behavioral effects o f ISS could be attributed, in part, to hypothermia, then it 
is possible that the organism’s compensatory response to cold recruits neurochemical 
systems to modulate thermogenesis that wouldn’t  be involved in normothermic or 
hyperthermic subjects. Cold exposure was found to increase the activity o f some DRN 
neurons in an in vitro slice preparation (Keenan & Chu, 1987) and increased brain levels 
of the 5-HT metabolite 5-HIAA after cold exposure (Algeri et al., 1982). However, 5-HT 
activity in the DRN or projection regions was unchanged during exposure to a cold room 
using in vivo microdialysis (Kirby, Chou-Green, Davis & Lucki, 1997) and 
electrophysiology (Martin-Cora, Fomal, Metzler, & Jacobs, 2000). Some evidence 
suggests that the DRN contributes to the thermogenesis through interconnections within 
the hypothalamus, as inhibition o f 5-HT with the 5 -H T ia  receptor agonist 8-OH-DPAT 
caused hypothermia (Hillegaart, 1991) and 5-HT injected into the hypothalamus 
increases core body temperature (Lin, Tsay, Su & Chueh, 1998). However, these 
manipulations may not parallel the endogenous thermogenesis response that is triggered 
by ISS. For the purpose of this discussion, while 5-HT appears to participate in the 
enhancement o f thermogenesis it does not appear to be critically involved in 
hypothermia.
Alternatives to Serotonin in the Intermittent Swim Stress Model 
The data reported here do not support the original hypothesis that the immobility 
produced by ISS in cold water is mediated by the 5-HT system. However, much is known
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about the physiological basis o f swim and hypothermia stress effects in the FST. As 
reviewed in Chapter III, intermittent shock stress affected almost every neurochemical 
system measured, but only 5-HT appears to be critical to the development of the learned 
helplessness behavior. The purpose of the following discussion is to suggest roles for 
three endogenous systems that could, in part or whole, account for the behavioral 
immobility produced by ISS.
Painful stimuli trigger the release o f endogenous opioid peptides; ISS is no 
exception. In fact, Girardot & Holloway (1984a) found that 18, 10 sec exposures to 
swimming 2°C water distributed equally over 3 min produced a stress-induced analgesia 
(SIA) that was blocked by the opiate antagonist naltrexone. Equal time, 3.5 min, of 
continuous swim stress in 2°C water produced a non-opioid analgesia. Furthermore, the 
chronic intermittent cold water stress was found to be cross-tolerant to morphine 
(Girardot & Holloway, 1984b). 3.5 min o f cold water swim stress in 4°C water produced 
profound reductions in binding of the opiate [3H]diprenophrine in many brain regions 
leading Seeger, Sforzo, Pert & Pert (1984) to write: “The changes induced by the cold 
water swim are so pervasive that they suggest a general ‘flooding’ o f the opiate receptors 
by endogenous opiates (Seeger et al., 1984, p. 310).” In accordance, the blood plasma 
concentration of /i-endorphin was increased after a 5 min swim in 1°C water (Vaswani, 
Richard & Tejwani, 1988). These reports may over emphasize the opioid involvement in 
cold water stress because the experimental procedures utilized much colder water (1 to 
4°C) that could be more painful than 15°C used in the ISS paradigm. Without assay of 
plasma /?-endorphin in the current studies it is impossible to determine how ISS compares
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to the observations reviewed here, but it is a distinct possibility that ISS causes the 
release o f endogenous opioids.
SIA by the release o f endogenous opioids could influence the behavioral 
adaptation to cold water by reducing the salience o f the painful stimuli. With less 
attention devoted to pain, the organism could attend to the, perhaps, more important 
environmental features o f swim: uncontrollability and inescapability. As will be 
discussed later, once the animal learns that swim is inescapable it should adopt an 
energy-preserving behavioral strategy such as immobility. Evidence to support this 
argument was reported using a chronic model of the intermittent cold water stress 
described above. Girardot & Holloway (1985) found that naltrexone attenuated, not only, 
the immobility observed in rats but also tolerance to SIA and to hypothermia after 
repeated intermittent cold water swim stress. Therefore, it is plausible that the cold water 
ISS induced immobility in the current experiments could be mediated by release of 
endogenous opioid peptides. Administration of the opiate antagonist naloxone before ISS 
or before the FST could test this hypothesis.
Exposure to ISS, regardless of temperature or controllability, causes a robust 
increase in circulating CORT (Drugan et al., 2005). CORT is known to influence many 
behaviors in the rat and could be an important regulator o f ISS induced immobility. In a 
set of elegant experiments, Jefferys, Copolov, Irby & Funder (1983) suggested that 
CORT is necessary for the increase in immobility produced by a 15 min swim observed 
24 h later in the 5 min FST. In their study, adrenalectomized rats spent less time climbing 
in the 5 min FST than sham-treated rats or rats with CORT replacement. It is known that 
basal levels of CORT are necessary for some forms o f memory (Sandi, 1998). Behavioral
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immobility in the FST is most likely an adaptive response that could involve memory for 
the swim environment. Mitchell & Meaney (1991) tested the role o f CORT in the 
consolidation o f such a memory. Andrenalectomized rats with CORT replacement before, 
but not after the 15 min swim did not display immobility, e.g. memory impaired. In 
contrast, adrenalectomized rats with continuous CORT replacement displayed 
immobility, e.g. memory intact. Because the adrenal gland is the source of peripheral 
catecholamines and endogenous opioids, the effects o f adrenalectomy on memory in the 
FST may not be isolated to CORT. Consistent with this limitation, Jefferys et al., (1983) 
observed that the anti-immobility effect of adrenalectomy was also reversed by an opiate 
agonist. Raised levels of CORT were observed after both escapable and inescapable ISS 
in 30°C but only inescapable ISS increased immobility (Drugan et al., 2005). In warm 
water, therefore, CORT does not appear to be the critical mediator o f ISS-induced 
immobility.
Though endogenous opioids and glucocorticoids may contribute to the 
phenomenon o f ISS induced immobility, far more empirical evidence implicates the brain 
NE system. Both electric shock and forced swimming increase the activity of NE neurons 
and stimulate release o f NE in brain (Weiss et al., 1981). In contrast to the role of 5-HT, 
however, NE may augment motivation or arousal during stress. Electrical stimulation 
(Kostowski, Danysz & Nowakowska, 1985) and microinjection o f NE (Weiss, Simson, 
Hoffman, Ambrose, Cooper & Webster, 1986) to the LC increased climbing in the FST 
without stimulating locomotor activity. Levels o f NE in frontal cortex are positively 
correlated with climbing and negatively correlated with immobility (Page, Brown & 
Lucki, 2003) and treatments that increase the availability o f NE such as the
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catecholamine precursor L-tyrosine (Yehiayan, Luo, Shukitt-Hale & Leiberman, 2001) or 
the NE specific reuptake inhibitor reboxetine (Page et al., 2003) reverse the effects of 
swim stress on immobility.
Consistent with these reports, we previously observed that rats with selective NE 
deafferentation in the region of the mPFC were behaviorally compromised during initial 
exposure to ISS (Christianson, Drugan & McGaughy, unpublished observations). After 
50-60 swim trials, the majority o f lesioned rats were unable to keep their heads above 
water during a 5 sec trial while all sham-lesioned rats maintained this criterion to 100 
trials. It appeared that lack of NE input to the mPFC impaired the behaviorally adaptive 
shift from highly active struggling to passive floating behavior that is typically observed 
during the ISS experience. Futhermore, I originally hypothesized that stress activated 5- 
HT and that 5-HT neurons relayed information about the stressor to the brain, something 
to the effect o f “pay attention!” In the learned helplessness model, where 5-HT is critical, 
physical activity is o f little adaptive importance because shock is administered to 
restrained animals. On the other hand, swim stress is a physically demanding experience 
in which survival is dependent on an adaptive strategy. NE could be released to maintain 
arousal and therefore facilitate active search/escape strategies such as climbing and 
diving. Several authors have hypothesized that prior experience with stress reduces the 
subsequent availability o f NE (Weiss, et al., 1970; Weiss et al., 1981) and sensitivity of 
LC neurons (Simson & Weiss, 1986) that may reduce arousal towards active behavioral 
strategies in a second exposure, either in a swim test (Jordan, Kramer, Zukas & Petty, 
1994) or in a shuttlebox (Anisman, Irwin & Sklar, 1979).
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At least three hypotheses exist in the literature regarding the role o f LC-NE in 
behavior during stress. One hypothesis, maintained by Simson & Weiss (1986) is that 
severe acute stress releases NE neurons from the normal auto-inhibition provided by NE 
binding at ai receptors on cell bodies. NE neurons, then, are hyper responsive to 
subsequent stressors. Simson & Weiss observe that the firing rate of NE neurons is 
inversely correlated with the degree o f depressed behaviors, i.e. floating in the FST. 
Unfortunately, the severe shock-stress procedure used by Weiss is unmatched in other 
paradigms making the results o f his studies difficult to relate to the ISS model. In 
contrast, Berridge & Waterhouse (2003) and Aston-Jones & Cohen (2005) posit a 
hypothetical role of NE in stress behaviors that may be applicable to ISS. Berridege & 
Waterhouse (2003) report that two fundamental functions of NE, behavioral 
maintenance/arousal and modulation o f sensory processing, are a critical substrate o f the 
behavioral consequences o f stress. Specifically, NE would be released to support fight- 
or-flight behaviors and also facilitate the processing o f environmental stimuli. Aston- 
Jones & Cohen (2005) considered the inhibitory control of the LC from the mPFC. As is 
described below, their so-called “Adaptive-Gain” Theory accounts for the transition from 
highly active to passive behaviors observed in the ISS paradigm.
I have sketched a neural circuit to account for the behavioral depression produced 
by ISS (Figure 12). In the hypothetical instance thatN E is the critical neurochemical 
substrate of ISS induced immobility, NE neurons, with cell bodies in the locus correleus 
(LC), become active during ISS. These neurons may relay information about the stress 
environment to the mPFC and modulate output from primary motor cortex and the basal 
ganglia to augment the initiation of voluntary climbing movements that orient the rat to
78
Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.
escape. Aston-Jones & Cohen (2005) have theorized that the LC makes a significant 
contribution to the mPFC when selecting adaptive behavioral strategies. mPFC is situated 
to modify behavior because it receives information about the physiological state of the 
organism, memory and the external environment.
The LC afferents to the mPFC display tonic and phasic firing patterns, ft is 
hypothesized that phasic activity in the LC is correlated with useful task-related 
behaviors and serve to exploit the behaviors that will optimize performance. Tonic firing 
is theorized to facilitate exploration or “behavioral sampling” o f behaviors that may be 
adaptive or rewarding, fn the FST, rats typically display a variety of behaviors 
immediately including immobility, climbing and diving, fn this initial stage it is likely 
that the LC is in a tonic firing pattern. However, the rat appears to make an adaptive shift 
away from behavioral sampling and exploits one behavior, immobility. This shift could 
be the result o f an appraisal process in the mPFC. In time, the rat may perceive the swim 
tank as an inescapable environment; the mPFC can account for this environmental 
information as well as the physiological state which should cause a shift towards the 
behavior strategy that will conserve energy. After sampling several behaviors, the rat may 
choose floating and exploit it. According to the theory of Aston-Jones & Cohen, when 
one behavior is predominant, the LC is in a phasic firing pattern.
The Adaptive-Gain Theory presented by Aston-Jones and Cohen (2005) seems to account 
for the behavioral pattern that is observed in our rats. That is, upon exposure to swim 
stress rats exhibit primarily active behaviors that, with time, gradually become passive. 
Animals that have more experience with stress, i.e. those exposed to ISS, are able to shift 
from a behavioral sampling of active behaviors to exploitation o f the passive immobile
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behavior that will increase the likelihood of survival. The circuit drawn in Figure 12 
includes bottom-up connections from the LC to the basal ganglia and primary motor 
cortex where voluntary movements, such as climbing or floating, would be initiated. 
Afferents from motor neurons may inform mPFC of the organism’s active state and 
efferents from mPFC may modify behavior according to the appraisal process described 
above.
Motor C ortex  
Basal G anglia
mPFC
Limbic System  
Am ygdala
LC-NE
Figure 12. A h y p o th e tica l m odel of LC-NE activity during in e s c a p a b le  stress. Stress 
stimulates neurons in LC. Initially, LC afferents to  m otor circuits a n d  th e  mPFC m ay 
facilitate high activity. However, in tim e th e  mPFC m ay  a p p ra ise  th e  stressor as 
in e sc a p a b le  a n d  th e re fo re  inhibit th e  m otor activity a n d  re g u la te  th e  LC to  re d u c e  
arousal or exploit less ac tiv e , a n d  m ore ad a p tiv e , behav io r. In anim als previously 
ex p o sed  to  stress, th e  mPFC m ay  b e  a b le  to  recall co n tex tu a l inform ation from th e  
limbic system a n d  s p e e d  th e  shift to  inactivity th a t is typically o b se rv e d  as behav io ral 
depression. H ashed  lines in d ica te  inhibitory pathw ays.
Tests that involve swimming, e.g. FST, SET and Morris Water Maze, are 
sensitive to ISS but tests in other contextual conditions, e.g. the open field and shuttle 
box, are not. It is possible that ISS-induced immobility is context dependent; therefore, 
limbic structures that are implicated in learning and memory could play an important 
function in the ISS phenomenon. The hippocampus and basolateral amygdala are
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modulated by endogenous opioids, glucocorticoids, acytelcholine and NE and is critical 
for the consolidation o f emotional memories (McGaugh, 2004). In the initial exposure to 
ISS, these structures may facilitate encoding of contextual information such as features of 
the stressor and the stress environment (Phillips & LeDoux, 1992). On the second 
exposure to swim in the FST, this information may be available to the mPFC and 
influence the adaptive shift to immobility.
After a great deal o f speculation regarding the potential biological mediators of 
ISS-induced immobility, what is left to conclude about controllable ISS? Immobility is 
not increased after escapable ISS (Drugan et al., 2005). I f  the neurobiological substrate of 
coping is not stressor-specific, then it is plausible that the mPFC, which is critical for the 
protective effect o f coping with intermittent shock (Amat et al., 2005), contributes to the 
benefit of coping observed in the ISS paradigm. Consistent with the model described in 
Figure 12, an organism that has learned a contingency for escape in the initial ISS 
treatment, in this case pressing an omni-directional lever, would not show the adaptive- 
shiftto immobility that is typical o f uncontrollable ISS. On the contrary, the mPFC may 
choose to exploit a more active behavior that is optimal for escape. On the second 
exposure to swimming in the FST, where escape is impossible but the context is similar, 
the rat may persevere with escape-oriented behavior like climbing longer than a rat that 
was treated previously with inescapable stress.
I have argued that the behavioral consequences o f ISS may be attributed to a 
stress-induced immobility (as described in Chapter II) that is caused in one part by 
exposure to an inescapable stressor where immobile behavior is adaptive and another by 
sensitization o f the brain LC-NE system. To test this hypothesis I will conduct studies
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that systematically manipulate the activity o f rats during stress or the intensity of stress, 
e.g. cold and high activity (large diameter cylinder) should cause greater immobility 
while warm water and low activity (narrow cylinder/restraint) should cause no 
immobility. Concomitant changes in NE could be observed using microdialysis 
techniques or the availability o f NE before stress could be manipulated with 
noradrenergic drugs.
Conclusion
In this thesis I have described the development of a new stress model called the 
intermittent swim stress (ISS) paradigm. In my hands, exposure to inescapable ISS 
caused increased behavioral immobility in the forced swimming test and interfered with 
escape learning in a swim-motivated test. These behavioral phenomena may be analogous 
to a subset of the symptoms of human depression or post traumatic stress disorder, such 
as reduced behavioral activity and cognitive deficits, and therefore the model could be a 
useful tool for studying the biological components o f stress and pathological behavior. To 
this end, a hypothesis implicating the brain serotonin system was tested in three 
experiments. The results provide no empirical support for a serotonergic role in the ISS 
phenomena. These null results could set ISS apart from current empirical models such as 
the continuous forced swim and intermittent shock paradigms that have a clear serotonin 
component. The behavioral nature of the ISS phenomenon can be described most simply 
as one of behavioral immobility as the result o f inescapable stress exposure. Much 
research suggests that such a behavior could be regulated by endogenous opioids, 
corticosterone or norepinephrine. Future work with the ISS model will be based on a 
hypothesis that considers the role o f these neurochemicals in the adaptive shift from
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active to passive behaviors that is present when an organism is exposed to physically 
demanding stressors. Behavioral inactivity could be the result of top-down regulation 
from mPFC to the LC that begins when the rat has appraised the environment as 
inescapable and must choose a behavioral strategy that promotes survival, such as 
immobility.
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APPENDIX A
U n i v e r s i t y  o f  N e w  H a m p s h i r e
Office of Sponsored Research 
Service Building 
51 College Road
Durham, New Hampshire 03824-3585 
(603) 862-3564 FAX
LAST NAME Drugan











Exploratory analysis o f a novel swim-stress escape test that may measure behavioral depression
Alt cage, pen or other animal identification records must include pour IA CUC Protocol # as listed above.
The Institutional Animal Care and Use Committee (1ACUC) has reviewed and approved the protocol submitted for this study 
under Category E  on Page 4 o f the “Application for Review of Animal Use in Research or Instruction" - the study involves pain, 
discomfort or distress (greater than that attending a routine injection) which cannot/wili not he alleviated through the 
administration of appropriate anesthetic, analgesic or tranquilizer drugs. The IACUC made the following comments on this 
protocol -  comments are usually minor editorial changes or clarifications that do not affect approval status (unlike contingencies, 
which require investigator action for initial or continuing approval):
Prior 0  involving animals in the study, John Christianson needs to m e t  with Van Gould and Bob hfair to review the 
procedures.
Approval is granted for a period of three years from the approval date above. Continued approval throughout the three year 
period is contingent upon completion of annual reports on the use of animals. At the end of the three year approval period you 
may submit a new application and request for extension to continue this project. Requests for extension must be filed prior to the 
expiration of the original approval.
Please note: Use of animals in research and instruction is approved contingent upon participation in the UNH Occupational 
Health Program for persons handling animals. Participation is mandatory for all principal investigators and their affiliated 
personnel, employees o f the University and students alike. A Medical History Questionnaire accompanys this approval; please 
copy and distribute to  all listed project staff who have not completed this form already. Completed questionnaires should be sent 
to Dr. Giadi Porsche, UNH Health Services. Thank you.
If you have any questions, please contact either Van Gould at 862-4629 or Julie Simpson at 862-2003.
IACUC,
G
bn A. Litvaitis, Ph.D.
Chair
cc: File
<JJohn P. Christianson, Graduate Student
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A P P E N D IX  B
U n i v e r s i t y  of N e w  H a m p s h i r e
September 29,2004





Approval Date: 09/22/2004 
Renew Level; E
Project: Intermittent Swim Stress Induced Behaviors in a Swim Escape Test
The Institutional Animal Care and Use committee (IACUC) reviewed and approved the protocol 
submitted for this study under Category E on Page 4 of the Application for Review of Vertebrate 
Animal Use in Research or Instruction - the research involves pain, discomfort or distress (greater 
than that attending a routine injection) which cannot/wiii not be alleviated through die 
administration o f appropriate anesthetic, analgesic or tranquilizer drugs.
Approval is granted for a period of three years from the approval date above. Continued approval 
throughout the three year period is contingent upon completion of annual reports on the use of 
animals. At the end of the three year approval period you may submit a new application and 
request for extension to continue this project. Requests for extension must be filed prior to the 
expiration of the original approval.
Please Note;
1. All cage, pen, or other animal identification records must include your IACUC #  listed above.
1. Use of animals in research and instruction Is approved contingent upon participation in the 
UNH Occupational Health Program for persons handling animals. Participation is mandatory 
for all principal investigators and their affiliated personnel, employees of the University and. 
students alike. A Medical History Questionnaire accompanies this approval; please copy and 
distribute to all listed project staff who have not completed this form already. Completed 
questionnaires should be sent to Dr. Gladi Porsche, UNH Health Services.






Research Conduct and Compliance Services, Office of Sponsored Research, Service Building, 
51 College Road, Durham, NH 03824-3585 * Fax; 603-862-3564
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APPENDIX C ____________________
^ [ U n i v e r s i t y  of N e w  H a m p s h i r e
March 28, 2005
Drugan, Robert 
Psychology, Conant Hall 
Durham, NH 03824
IACUC # : 050302
Approval Date: 03/25/2005 
Review Level: E
project: Do Antidepressants with Opposite Actions on Serotonin Uptake Produce Opposite
Behavioral Reactions to Intermittent Swim Stress?
The Institutional Animal Care and Use Committee (IACUC) reviewed and approved the protocol 
submitted for this study under Category E on Page 4 of the Application for Review of Vertebrate 
Animal Use in Research or Instruction - the research involves pain, discomfort or distress (greater 
than that attending a routine injection) which cannot/will not be alleviated through the 
administration o f appropriate anesthetic, analgesic or tranquilizer drugs. The IACUC made the 
following comments on tills protocol:
In Section V, C, (evaluation o f outcomes), the Committee checked "Other* and added "Any 
animals exhibiting signs of pain or distress wiii be removed from the study. *
Approval is granted for a period of three years from the approval date above. Continued approvai 
throughout the three year period is contingent upon completion of annual reports on the use of 
animals. At the end of the three year approval period you may submit a new application and 
request for extension to continue this project Requests for extension must be filed prior to the 
expiration of the original approval.
Please Note:
1. All cage, pen, or other animal identification records must include your IACUC #  listed above.
2. Use of animals in research and instruction is approved contingent upon participation in the 
UNH Occupational Health Program for persons handling animals. Participation is mandatory 
for all principal investigators and their affiliated personnel, employees of the University and 
students alike. A Medical History Questionnaire accompanies this approval; please copy and 
distribute to all IKted project staff who have not completed this form already. Completed 
questionnaires should be sent to Dr. Gladi Porsche, UNH Health Services.
If you have any questions, please contact either Van Goutd at 862-4629 or Julie Simpson at 862- 
2003.
& r the IACUC,
Robert G. Mair, Ph.D.
Chair
cc: File
Research Conduct and Compliance Services, Office of Sponsored Research, Service Building, 
51 College Road, Durham, NH 03824*3585 * Fax: 603*862*3564
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APPENDIX D 
U n i v e r s i t y  o f N e w  H a m p s h i r e
February 2, 2006
Drugan, Robert 
Psychology, Conant Hall 
Durham, NH 03824
IA CUC#: 060104
Approval Date: 01/27/2006 
Review Level: E
Project: Effect of Serotonin Depletion on Intermittent Swim Stress Induced Mobility
The Institutional Animal Care and Use Committee (IACUC) reviewed and approved the protocol 
submitted for this study under Category E on Page 4 of the Application for Review of Vertebrate 
Animal Use in Research or Instruction - the research involves pain, discomfort or distress (greater 
than that attending a routine injection) which cannot/will not be alleviated through the 
administration o f appropriate anesthetic, analgesic or tranquilizer drugs. The IACUC made the 
following comments on this protocol:
1. In Section II, F, (basic application information, attributes), the Committee checked 
"Euthanasia.*
2. In Section III, A (summary o f proposed animal use), the investigator needs to remove 
the last four sentences (as they repeat information provided in part B) and shorten the 
remaining information to fit within the text box provided.
3. The investigator needs to add to the end o f the information provided in Section IV, A 
(experimental design) a statement that all animals are euthanized a t the end o f the 
study.
Approval is granted for a period of three years from the approval date above. Continued approval 
throughout the three year period is contingent upon completion of annual reports on the use of 
animals. At the end of the three year approval period you may submit a  new application and 
request for extension to continue this project. Requests for extension must be filed prior to the 
expiration of the original approval.
Please Note:
1. All cage, pen, or other animal identification records m ist include your IACUC #  listed above.
2. Use of animals in research and instruction is approved contingent upon participation in the 
UNH Occupational Health Program for persons handling animals. Participation is mandatory 
for all principal investigators and their affiliated personnel, employees of the University and 
students alike. A Medical History Questionnaire accompanies this approval; please copy and 
distribute to all listed project staff who have not completed this form already. Completed 
questionnaires should be sent to Dr. Gladi Porsche, UNH Health Services.
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If  you have arty questions, please contact either Roger Wells at 862*2726 or Julie Simpson at 862- 
2003.
For the IACUC,.
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